ONTOLOGY REPORT - ANNOTATIONS
| Term: | phenobarbital |
|
| Accession: | CHEBI:8069
|
browse the term
|
| Definition: | Barbituric acid substituted at C-5 by ethyl and phenyl groups. |
| Synonyms: | related_synonym: | 5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione; 5-Ethyl-5-phenylbarbituric acid; 5-Phenyl-5-ethylbarbituric acid; 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione; C12H12N2O3; CCC1(C(=O)NC(=O)NC1=O)c1ccccc1; InChI=1S/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17); InChIKey=DDBREPKUVSBGFI-UHFFFAOYSA-N; Luminal; PHENYLETHYLMALONYLUREA; Phenobarbitol; Phenobarbitone; Phenobarbituric Acid; Phenylaethylbarbitursaeure; Phenylethylbarbiturate; Phenylethylbarbituric Acid; Phenylethylbarbitursaeure |
| | alt_id: | CHEBI:102217 |
| | xref_casrn: | 50-06-6 |
| | xref: | Beilstein:233363 "Beilstein Registry Number"; ChEMBL:102217 "ChEMBL COMPOUND"; ChEMBL:10866370 "PubMed citation"; ChEMBL:10891117 "PubMed citation"; ChEMBL:11311072 "PubMed citation"; ChEMBL:12361404 "PubMed citation"; ChEMBL:12873507 "PubMed citation"; ChEMBL:1495012 "PubMed citation"; ChEMBL:15324906 "PubMed citation"; ChEMBL:15857133 "PubMed citation"; ChEMBL:16139502 "PubMed citation"; ChEMBL:16190747 "PubMed citation"; ChEMBL:16789751 "PubMed citation"; ChEMBL:16793262 "PubMed citation"; ChEMBL:1681105 "PubMed citation"; ChEMBL:17300161 "PubMed citation"; ChEMBL:17481896 "PubMed citation"; ChEMBL:17827020 "PubMed citation"; ChEMBL:17870541 "PubMed citation"; ChEMBL:1875341 "PubMed citation"; ChEMBL:1992141 "PubMed citation"; ChEMBL:2061925 "PubMed citation"; ChEMBL:2170646 "PubMed citation"; ChEMBL:2296016 "PubMed citation"; ChEMBL:2308141 "PubMed citation"; ChEMBL:2308142 "PubMed citation"; ChEMBL:2579237 "PubMed citation"; ChEMBL:2724304 "PubMed citation"; ChEMBL:3016269 "PubMed citation"; ChEMBL:3336019 "PubMed citation"; ChEMBL:3572984 "PubMed citation"; ChEMBL:3599019 "PubMed citation"; ChEMBL:3735320 "PubMed citation"; ChEMBL:3783589 "PubMed citation"; ChEMBL:3783590 "PubMed citation"; ChEMBL:3820228 "PubMed citation"; ChEMBL:3950916 "PubMed citation"; ChEMBL:3950919 "PubMed citation"; ChEMBL:4032429 "PubMed citation"; ChEMBL:6716399 "PubMed citation"; ChEMBL:6737420 "PubMed citation"; ChEMBL:6864729 "PubMed citation"; ChEMBL:7205879 "PubMed citation"; ChEMBL:7381857 "PubMed citation"; ChEMBL:7562939 "PubMed citation"; ChEMBL:7799408 "PubMed citation"; ChEMBL:8035421 "PubMed citation"; ChEMBL:8230125 "PubMed citation"; ChEMBL:8246220 "PubMed citation"; ChEMBL:8627613 "PubMed citation"; ChEMBL:8691481 "PubMed citation"; ChEMBL:9016327 "PubMed citation"; ChEMBL:9544213 "PubMed citation"; ChemIDplus:50-06-6 "CAS Registry Number"; CiteXplore:3654008 "PubMed citation"; DrugBank:DB01174 "DrugBank"; Gmelin:336231 "Gmelin Registry Number"; KEGG COMPOUND:50-06-6 "CAS Registry Number"; KEGG COMPOUND:C07434 "KEGG COMPOUND"; KEGG DRUG:D00506 "KEGG DRUG" |
| | xref_mesh: | MESH:D010634 |
| | xref: | NIST Chemistry WebBook:50-06-6 "CAS Registry Number"; Patent:US1025872 "Patent"; Wikipedia:Phenobarbital "Wikipedia" |
|
|
phenobarbital
|
| G |
Abca6 |
ATP-binding cassette, subfamily A (ABC1), member 6 |
|
increases expression |
ISO |
10 |
99,626,334 |
99,693,870 |
RGD:6480464 |
CTD |
| G |
Abi3bp |
ABI family, member 3 (NESH) binding protein |
|
affects expression |
ISO |
11 |
44,853,302 |
45,072,354 |
RGD:6480464 |
CTD |
| G |
Anln |
anillin, actin binding protein |
|
multiple interactions |
ISO |
8 |
21,642,021 |
21,721,815 |
RGD:6480464 |
CTD |
| G |
Anln |
anillin, actin binding protein |
|
increases expression |
ISO |
8 |
21,642,021 |
21,721,815 |
RGD:6480464 |
CTD |
| G |
Arih1 |
ariadne homolog, ubiquitin-conjugating enzyme E2 binding protein, 1 (Drosophila) |
|
increases expression |
ISO |
8 |
63,201,871 |
63,305,302 |
RGD:6480464 |
CTD |
| G |
Atg14 |
autophagy related 14 |
|
increases expression |
ISO |
15 |
23,511,665 |
23,543,023 |
RGD:6480464 |
CTD |
| G |
Atp5o |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
increases expression |
EXP |
11 |
31,914,320 |
31,920,632 |
RGD:6480464 |
CTD |
| G |
Bach2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
|
decreases expression |
ISO |
5 |
48,611,805 |
48,881,943 |
RGD:6480464 |
CTD |
| G |
Bmp8b |
bone morphogenetic protein 8b |
|
multiple interactions |
ISO |
5 |
142,421,940 |
142,440,765 |
RGD:6480464 |
CTD |
| G |
Bmp8b |
bone morphogenetic protein 8b |
|
increases expression |
ISO |
5 |
142,421,940 |
142,440,765 |
RGD:6480464 |
CTD |
| G |
Brwd3 |
bromodomain and WD repeat domain containing 3 |
|
affects expression |
ISO |
X |
97,008,947 |
97,131,275 |
RGD:6480464 |
CTD |
| G |
C1qtnf4 |
C1q and tumor necrosis factor related protein 4 |
|
affects expression |
ISO |
3 |
75,248,277 |
75,252,715 |
RGD:6480464 |
CTD |
| G |
Camk1d |
calcium/calmodulin-dependent protein kinase ID |
|
decreases expression |
ISO |
17 |
83,649,720 |
84,061,160 |
RGD:6480464 |
CTD |
| G |
Car14 |
carbonic anhydrase 14 |
|
multiple interactions |
ISO |
2 |
190,683,916 |
190,690,229 |
RGD:6480464 |
CTD |
| G |
Car14 |
carbonic anhydrase 14 |
|
decreases expression |
ISO |
2 |
190,683,916 |
190,690,229 |
RGD:6480464 |
CTD |
| G |
Ccdc122 |
coiled-coil domain containing 122 |
|
increases expression |
ISO |
15 |
58,510,558 |
58,538,200 |
RGD:6480464 |
CTD |
| G |
Cd209f |
CD209f antigen |
|
decreases expression |
ISO |
12 |
1,657,463 |
1,660,482 |
RGD:6480464 |
CTD |
| G |
Cdca5 |
cell division cycle associated 5 |
|
increases expression |
ISO |
1 |
210,247,351 |
210,247,881 |
RGD:6480464 |
CTD |
| G |
Cdhr5 |
cadherin-related family member 5 |
|
multiple interactions |
ISO |
1 |
201,462,419 |
201,470,823 |
RGD:6480464 |
CTD |
| G |
Cdhr5 |
cadherin-related family member 5 |
|
increases expression |
ISO |
1 |
201,462,419 |
201,470,823 |
RGD:6480464 |
CTD |
| G |
Cenpp |
centromere protein P |
|
multiple interactions |
ISO |
17 |
20,969,057 |
21,145,366 |
RGD:6480464 |
CTD |
| G |
Cenpp |
centromere protein P |
|
increases expression |
ISO |
17 |
20,969,057 |
21,145,366 |
RGD:6480464 |
CTD |
| G |
Clasp1 |
cytoplasmic linker associated protein 1 |
|
multiple interactions |
ISO |
13 |
31,046,104 |
31,269,294 |
RGD:6480464 |
CTD |
| G |
Clasp1 |
cytoplasmic linker associated protein 1 |
|
increases expression |
ISO |
13 |
31,046,104 |
31,269,294 |
RGD:6480464 |
CTD |
| G |
Clec2h |
C-type lectin domain family 2, member H |
|
increases expression |
ISO |
4 |
166,193,710 |
166,299,866 |
RGD:6480464 |
CTD |
| G |
Colec11 |
collectin sub-family member 11 |
|
multiple interactions |
ISO |
6 |
46,466,449 |
46,504,760 |
RGD:6480464 |
CTD |
| G |
Colec11 |
collectin sub-family member 11 |
|
decreases expression |
ISO |
6 |
46,466,449 |
46,504,760 |
RGD:6480464 |
CTD |
| G |
Cyp2b13 |
cytochrome P450, family 2, subfamily b, polypeptide 13 |
|
multiple interactions |
ISO |
1 |
81,408,436 |
81,582,029 |
RGD:6480464 |
CTD |
| G |
Cyp2b13 |
cytochrome P450, family 2, subfamily b, polypeptide 13 |
|
increases expression |
ISO |
1 |
81,408,436 |
81,582,029 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases expression |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
affects metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases expression |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
increases expression |
ISO |
1 |
243,859,015 |
243,896,003 |
RGD:6480464 |
CTD |
| G |
Dcst2 |
DC-STAMP domain containing 2 |
|
multiple interactions |
ISO |
2 |
181,560,294 |
181,574,666 |
RGD:6480464 |
CTD |
| G |
Desi2 |
desumoylating isopeptidase 2 |
|
decreases expression |
ISO |
13 |
93,895,171 |
93,903,458 |
RGD:6480464 |
CTD |
| G |
Dexi |
dexamethasone-induced transcript |
|
decreases expression |
ISO |
10 |
5,072,036 |
5,084,723 |
RGD:6480464 |
CTD |
| G |
Dexi |
dexamethasone-induced transcript |
|
multiple interactions |
ISO |
10 |
5,072,036 |
5,084,723 |
RGD:6480464 |
CTD |
| G |
Eif1 |
eukaryotic translation initiation factor 1 |
|
affects expression |
ISO |
10 |
89,255,637 |
89,257,728 |
RGD:6480464 |
CTD |
| G |
Endod1 |
endonuclease domain containing 1 |
|
multiple interactions |
ISO |
8 |
11,151,051 |
11,180,463 |
RGD:6480464 |
CTD |
| G |
Endod1 |
endonuclease domain containing 1 |
|
increases expression |
ISO |
8 |
11,151,051 |
11,180,463 |
RGD:6480464 |
CTD |
| G |
Enpep |
glutamyl aminopeptidase |
|
increases expression |
EXP |
2 |
226,731,079 |
226,732,069 |
RGD:6480464 |
CTD |
| G |
Fhad1 |
forkhead-associated (FHA) phosphopeptide binding domain 1 |
|
multiple interactions |
ISO |
5 |
160,790,716 |
160,869,013 |
RGD:6480464 |
CTD |
| G |
Fhad1 |
forkhead-associated (FHA) phosphopeptide binding domain 1 |
|
increases expression |
ISO |
5 |
160,790,716 |
160,869,013 |
RGD:6480464 |
CTD |
| G |
Fndc5 |
fibronectin type III domain containing 5 |
|
increases expression |
ISO |
5 |
148,296,328 |
148,304,372 |
RGD:6480464 |
CTD |
| G |
Gadl1 |
glutamate decarboxylase-like 1 |
|
affects methylation |
ISO |
8 |
120,428,678 |
120,579,318 |
RGD:6480464 |
CTD |
| G |
Golm1 |
golgi membrane protein 1 |
|
multiple interactions |
ISO |
17 |
10,911,513 |
10,938,960 |
RGD:6480464 |
CTD |
| G |
Golm1 |
golgi membrane protein 1 |
|
increases expression |
ISO |
17 |
10,911,513 |
10,938,960 |
RGD:6480464 |
CTD |
| G |
Gsap |
gamma-secretase activating protein |
|
increases expression |
ISO |
4 |
9,306,309 |
9,401,421 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
multiple interactions |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Ifitm1 |
interferon induced transmembrane protein 1 |
|
multiple interactions |
ISO |
1 |
201,154,494 |
201,155,509 |
RGD:6480464 |
CTD |
| G |
Ifitm1 |
interferon induced transmembrane protein 1 |
|
decreases expression |
ISO |
1 |
201,154,494 |
201,155,509 |
RGD:6480464 |
CTD |
| G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
decreases expression |
ISO |
X |
8,758,662 |
8,820,545 |
RGD:6480464 |
CTD |
| G |
Irs4 |
insulin receptor substrate 4 |
|
affects expression |
ISO |
X |
36,881,414 |
36,885,105 |
RGD:6480464 |
CTD |
| G |
Itga3 |
integrin, alpha 3 |
|
affects expression |
ISO |
10 |
83,728,710 |
83,759,576 |
RGD:6480464 |
CTD |
| G |
Large |
like-glycosyltransferase |
|
multiple interactions |
ISO |
19 |
12,043,818 |
12,497,663 |
RGD:6480464 |
CTD |
| G |
Large |
like-glycosyltransferase |
|
affects methylation |
ISO |
19 |
12,043,818 |
12,497,663 |
RGD:6480464 |
CTD |
| G |
Large |
like-glycosyltransferase |
|
increases expression |
ISO |
19 |
12,043,818 |
12,497,663 |
RGD:6480464 |
CTD |
| G |
Lcorl |
ligand dependent nuclear receptor corepressor-like |
|
multiple interactions |
ISO |
14 |
70,330,344 |
70,435,179 |
RGD:6480464 |
CTD |
| G |
Lcorl |
ligand dependent nuclear receptor corepressor-like |
|
increases expression |
ISO |
14 |
70,330,344 |
70,435,179 |
RGD:6480464 |
CTD |
| G |
Lin52 |
lin-52 homolog (C. elegans) |
|
increases expression |
ISO |
6 |
108,516,945 |
108,601,602 |
RGD:6480464 |
CTD |
| G |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
|
affects methylation |
ISO |
5 |
52,476,741 |
52,590,042 |
RGD:6480464 |
CTD |
| G |
LOC100360218 |
interleukin 13 receptor, alpha 1-like |
|
multiple interactions |
ISO |
11 |
73,147,318 |
73,148,958 |
RGD:6480464 |
CTD |
| G |
LOC100360218 |
interleukin 13 receptor, alpha 1-like |
|
decreases expression |
ISO |
11 |
73,147,318 |
73,148,958 |
RGD:6480464 |
CTD |
| G |
LOC100363014 |
REST corepressor 1-like |
|
decreases expression |
ISO |
6 |
135,779,610 |
135,858,591 |
RGD:6480464 |
CTD |
| G |
Lrp11 |
low density lipoprotein receptor-related protein 11 |
|
multiple interactions |
ISO |
1 |
2,255,892 |
2,284,328 |
RGD:6480464 |
CTD |
| G |
Lrp11 |
low density lipoprotein receptor-related protein 11 |
|
increases expression |
ISO |
1 |
2,255,892 |
2,284,328 |
RGD:6480464 |
CTD |
| G |
Ly96 |
lymphocyte antigen 96 |
|
multiple interactions |
ISO |
5 |
1,701,969 |
1,705,247 |
RGD:6480464 |
CTD |
| G |
Ly96 |
lymphocyte antigen 96 |
|
increases expression |
ISO |
5 |
1,701,969 |
1,705,247 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
increases expression |
ISO |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
increases expression |
ISO |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Mfsd11 |
major facilitator superfamily domain containing 11 |
|
increases expression |
ISO |
10 |
106,957,529 |
106,973,225 |
RGD:6480464 |
CTD |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
increases expression |
ISO |
6 |
11,525,292 |
11,542,592 |
RGD:6480464 |
CTD |
| G |
Myl6b |
myosin, light chain 6B, alkali, smooth muscle and non-muscle |
|
affects expression |
ISO |
7 |
1,775,930 |
1,779,332 |
RGD:6480464 |
CTD |
| G |
Nek2l1 |
NIMA (never in mitosis gene a)-related kinase 2-like 1 |
|
multiple interactions |
ISO |
8 |
14,245,342 |
14,246,673 |
RGD:6480464 |
CTD |
| G |
Nek2l1 |
NIMA (never in mitosis gene a)-related kinase 2-like 1 |
|
increases expression |
ISO |
8 |
14,245,342 |
14,246,673 |
RGD:6480464 |
CTD |
| G |
Notum |
notum pectinacetylesterase homolog (Drosophila) |
|
decreases expression |
ISO |
10 |
110,047,040 |
110,054,106 |
RGD:6480464 |
CTD |
| G |
Notum |
notum pectinacetylesterase homolog (Drosophila) |
|
multiple interactions |
ISO |
10 |
110,047,040 |
110,054,106 |
RGD:6480464 |
CTD |
| G |
Notum |
notum pectinacetylesterase homolog (Drosophila) |
|
increases expression |
ISO |
10 |
110,047,040 |
110,054,106 |
RGD:6480464 |
CTD |
| G |
Oaz2 |
ornithine decarboxylase antizyme 2 |
|
increases expression |
ISO |
8 |
69,935,001 |
69,948,824 |
RGD:6480464 |
CTD |
| G |
Pald1 |
phosphatase domain containing, paladin 1 |
|
decreases expression |
ISO |
20 |
28,682,111 |
28,718,682 |
RGD:6480464 |
CTD |
| G |
Papss1 |
3'-phosphoadenosine 5'-phosphosulfate synthase 1 |
|
increases expression |
ISO |
2 |
229,005,799 |
229,040,958 |
RGD:6480464 |
CTD |
| G |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
|
multiple interactions |
ISO |
20 |
10,541,656 |
10,563,199 |
RGD:6480464 |
CTD |
| G |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
|
increases expression |
ISO |
20 |
10,541,656 |
10,563,199 |
RGD:6480464 |
CTD |
| G |
Pigr |
polymeric immunoglobulin receptor |
|
multiple interactions |
ISO |
13 |
43,785,845 |
43,819,331 |
RGD:6480464 |
CTD |
| G |
Pigr |
polymeric immunoglobulin receptor |
|
decreases expression |
ISO |
13 |
43,785,845 |
43,819,331 |
RGD:6480464 |
CTD |
| G |
Pigy |
phosphatidylinositol glycan anchor biosynthesis, class Y |
|
decreases expression |
ISO |
4 |
87,255,932 |
87,258,211 |
RGD:6480464 |
CTD |
| G |
Pigy |
phosphatidylinositol glycan anchor biosynthesis, class Y |
|
multiple interactions |
ISO |
4 |
87,255,932 |
87,258,211 |
RGD:6480464 |
CTD |
| G |
Pik3ap1 |
phosphoinositide-3-kinase adaptor protein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
increases expression |
EXP |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Pim3 |
pim-3 oncogene |
|
multiple interactions |
ISO |
7 |
127,167,984 |
127,172,018 |
RGD:6480464 |
CTD |
| G |
Pim3 |
pim-3 oncogene |
|
increases expression |
ISO |
7 |
127,167,984 |
127,172,018 |
RGD:6480464 |
CTD |
| G |
Pim3 |
pim-3 oncogene |
|
decreases expression |
ISO |
7 |
127,167,984 |
127,172,018 |
RGD:6480464 |
CTD |
| G |
Pipox |
pipecolic acid oxidase |
|
multiple interactions |
ISO |
10 |
63,920,814 |
63,933,307 |
RGD:6480464 |
CTD |
| G |
Pipox |
pipecolic acid oxidase |
|
decreases expression |
ISO |
10 |
63,920,814 |
63,933,307 |
RGD:6480464 |
CTD |
| G |
Pir |
pirin (iron-binding nuclear protein) |
|
multiple interactions |
ISO |
X |
50,864,981 |
50,974,861 |
RGD:6480464 |
CTD |
| G |
Pir |
pirin (iron-binding nuclear protein) |
|
increases expression |
ISO |
X |
50,864,981 |
50,974,861 |
RGD:6480464 |
CTD |
| G |
Pitpnm1 |
phosphatidylinositol transfer protein, membrane-associated 1 |
|
multiple interactions |
ISO |
1 |
206,684,110 |
206,697,483 |
RGD:6480464 |
CTD |
| G |
Pitpnm1 |
phosphatidylinositol transfer protein, membrane-associated 1 |
|
increases expression |
ISO |
1 |
206,684,110 |
206,697,483 |
RGD:6480464 |
CTD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
decreases expression |
ISO |
14 |
6,349,519 |
6,392,988 |
RGD:6480464 |
CTD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
multiple interactions |
ISO |
14 |
6,349,519 |
6,392,988 |
RGD:6480464 |
CTD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
decreases expression |
ISO |
14 |
6,349,519 |
6,392,988 |
RGD:6480464 |
CTD |
| G |
Pkhd1 |
polycystic kidney and hepatic disease 1 |
|
decreases expression |
ISO |
9 |
18,833,903 |
19,338,716 |
RGD:6480464 |
CTD |
| G |
Pkhd1 |
polycystic kidney and hepatic disease 1 |
|
multiple interactions |
ISO |
9 |
18,833,903 |
19,338,716 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
multiple interactions |
ISO |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
increases expression |
ISO |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
decreases expression |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pkm |
pyruvate kinase, muscle |
|
decreases expression |
ISO |
8 |
63,486,492 |
63,508,016 |
RGD:6480464 |
CTD |
| G |
Pkmyt1 |
protein kinase, membrane associated tyrosine/threonine 1 |
|
affects expression |
ISO |
10 |
12,982,319 |
12,993,706 |
RGD:6480464 |
CTD |
| G |
Pla2g12a |
phospholipase A2, group XIIA |
|
multiple interactions |
ISO |
2 |
227,331,049 |
227,348,091 |
RGD:6480464 |
CTD |
| G |
Pla2g12a |
phospholipase A2, group XIIA |
|
increases expression |
ISO |
2 |
227,331,049 |
227,348,091 |
RGD:6480464 |
CTD |
| G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
increases expression |
ISO |
5 |
157,654,786 |
157,657,360 |
RGD:6480464 |
CTD |
| G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
multiple interactions |
ISO |
5 |
157,654,786 |
157,657,360 |
RGD:6480464 |
CTD |
| G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
increases expression |
EXP |
5 |
157,654,786 |
157,657,360 |
RGD:6480464 |
CTD |
| G |
Pla2g6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
|
multiple interactions |
ISO |
7 |
117,266,784 |
117,307,172 |
RGD:6480464 |
CTD |
| G |
Pla2g6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
|
multiple interactions |
ISO |
7 |
117,266,784 |
117,307,172 |
RGD:6480464 |
CTD |
| G |
Pla2g6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
|
increases expression |
ISO |
7 |
117,266,784 |
117,307,172 |
RGD:6480464 |
CTD |
| G |
Plaa |
phospholipase A2, activating protein |
|
increases expression |
EXP |
5 |
114,869,341 |
114,899,356 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
multiple interactions |
ISO |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
increases expression |
ISO |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plcd4 |
phospholipase C, delta 4 |
|
increases expression |
EXP |
9 |
73,878,506 |
73,905,127 |
RGD:6480464 |
CTD |
| G |
Plcg2 |
phospholipase C, gamma 2 |
|
decreases expression |
EXP |
19 |
47,875,572 |
47,947,573 |
RGD:6480464 |
CTD |
| G |
Plcl2 |
phospholipase C-like 2 |
|
multiple interactions |
ISO |
9 |
4,687,320 |
4,873,780 |
RGD:6480464 |
CTD |
| G |
Plcl2 |
phospholipase C-like 2 |
|
decreases expression |
ISO |
9 |
4,687,320 |
4,873,780 |
RGD:6480464 |
CTD |
| G |
Plekha1 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
|
affects expression |
ISO |
1 |
190,187,202 |
190,238,309 |
RGD:6480464 |
CTD |
| G |
Plekhb1 |
pleckstrin homology domain containing, family B (evectins) member 1 |
|
decreases expression |
ISO |
1 |
158,081,932 |
158,096,197 |
RGD:6480464 |
CTD |
| G |
Plekhb1 |
pleckstrin homology domain containing, family B (evectins) member 1 |
|
multiple interactions |
ISO |
1 |
158,081,932 |
158,096,197 |
RGD:6480464 |
CTD |
| G |
Plekhg2 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
|
affects expression |
ISO |
1 |
83,469,392 |
83,482,599 |
RGD:6480464 |
CTD |
| G |
Plin2 |
perilipin 2 |
|
increases expression |
EXP |
5 |
105,718,496 |
105,732,817 |
RGD:6480464 |
CTD |
| G |
Plin3 |
perilipin 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Plin3 |
perilipin 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Plk1 |
polo-like kinase 1 |
|
increases expression |
ISO |
1 |
181,002,811 |
181,012,741 |
RGD:6480464 |
CTD |
| G |
Plk3 |
polo-like kinase 3 |
|
decreases expression |
ISO |
5 |
137,443,540 |
137,448,715 |
RGD:6480464 |
CTD |
| G |
Plk3 |
polo-like kinase 3 |
|
increases expression |
ISO |
5 |
137,443,540 |
137,448,715 |
RGD:6480464 |
CTD |
| G |
Plscr1 |
phospholipid scramblase 1 |
|
multiple interactions |
ISO |
8 |
97,206,388 |
97,226,725 |
RGD:6480464 |
CTD |
| G |
Plscr1 |
phospholipid scramblase 1 |
|
increases expression |
ISO |
8 |
97,206,388 |
97,226,725 |
RGD:6480464 |
CTD |
| G |
Pltp |
phospholipid transfer protein |
|
multiple interactions |
ISO |
3 |
155,871,842 |
155,889,959 |
RGD:6480464 |
CTD |
| G |
Pltp |
phospholipid transfer protein |
|
decreases expression |
ISO |
3 |
155,871,842 |
155,889,959 |
RGD:6480464 |
CTD |
| G |
Pltp |
phospholipid transfer protein |
|
increases expression |
ISO |
3 |
155,871,842 |
155,889,959 |
RGD:6480464 |
CTD |
| G |
Plvap |
plasmalemma vesicle associated protein |
|
decreases expression |
ISO |
16 |
18,668,569 |
18,678,431 |
RGD:6480464 |
CTD |
| G |
Plvap |
plasmalemma vesicle associated protein |
|
multiple interactions |
ISO |
16 |
18,668,569 |
18,678,431 |
RGD:6480464 |
CTD |
| G |
Plxna2 |
plexin A2 |
|
decreases expression |
ISO |
13 |
110,555,958 |
110,754,672 |
RGD:6480464 |
CTD |
| G |
Pmvk |
phosphomevalonate kinase |
|
affects expression |
ISO |
2 |
181,655,658 |
181,665,214 |
RGD:6480464 |
CTD |
| G |
Pnkd |
paroxysmal nonkinesigenic dyskinesia |
|
decreases expression |
ISO |
9 |
73,611,610 |
73,697,690 |
RGD:6480464 |
CTD |
| G |
Pnliprp1 |
pancreatic lipase-related protein 1 |
|
increases expression |
ISO |
1 |
265,237,786 |
265,253,415 |
RGD:6480464 |
CTD |
| G |
Pnliprp1 |
pancreatic lipase-related protein 1 |
|
multiple interactions |
ISO |
1 |
265,237,786 |
265,253,415 |
RGD:6480464 |
CTD |
| G |
Pnoc |
prepronociceptin |
|
increases expression |
EXP |
15 |
44,822,635 |
44,835,637 |
RGD:6480464 |
CTD |
| G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
|
increases expression |
ISO |
7 |
122,152,092 |
122,171,994 |
RGD:6480464 |
CTD |
| G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
|
multiple interactions |
ISO |
7 |
122,152,092 |
122,171,994 |
RGD:6480464 |
CTD |
| G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
|
increases expression |
EXP |
5 |
49,544,328 |
49,547,367 |
RGD:6480464 |
CTD |
| G |
Pnrc2 |
proline-rich nuclear receptor coactivator 2 |
|
increases expression |
ISO |
5 |
154,652,576 |
154,655,560 |
RGD:6480464 |
CTD |
| G |
Polg2 |
polymerase (DNA directed), gamma 2, accessory subunit |
|
increases expression |
EXP |
10 |
96,120,205 |
96,130,221 |
RGD:6480464 |
CTD |
| G |
Polr1b |
polymerase (RNA) I polypeptide B |
|
increases expression |
EXP |
3 |
116,706,483 |
116,730,946 |
RGD:6480464 |
CTD |
| G |
Pomp |
proteasome maturation protein |
|
increases expression |
EXP |
12 |
7,719,721 |
7,732,544 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
multiple interactions |
EXP |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
multiple interactions |
ISO |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
multiple interactions |
ISO |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
multiple interactions |
ISO |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases activity |
ISO |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
affects activity |
EXP |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases expression |
ISO |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases expression |
EXP |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases expression |
EXP |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Porcn |
porcupine homolog (Drosophila) |
|
affects expression |
ISO |
X |
26,317,388 |
26,330,177 |
RGD:6480464 |
CTD |
| G |
Postn |
periostin, osteoblast specific factor |
|
affects expression |
ISO |
2 |
143,537,099 |
143,568,341 |
RGD:6480464 |
CTD |
| G |
Pou2f1 |
POU class 2 homeobox 1 |
|
decreases expression |
ISO |
13 |
81,607,326 |
81,739,958 |
RGD:6480464 |
CTD |
| G |
Ppap2c |
phosphatidic acid phosphatase type 2c |
|
multiple interactions |
ISO |
7 |
11,694,272 |
11,702,348 |
RGD:6480464 |
CTD |
| G |
Ppap2c |
phosphatidic acid phosphatase type 2c |
|
decreases expression |
ISO |
7 |
11,694,272 |
11,702,348 |
RGD:6480464 |
CTD |
| G |
Ppap2c |
phosphatidic acid phosphatase type 2c |
|
increases expression |
ISO |
7 |
11,694,272 |
11,702,348 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
|
increases expression |
ISO |
14 |
33,509,364 |
33,543,743 |
RGD:6480464 |
CTD |
| G |
Ppp1r37 |
protein phosphatase 1, regulatory subunit 37 |
|
increases expression |
ISO |
1 |
78,884,411 |
78,886,491 |
RGD:6480464 |
CTD |
| G |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
|
increases expression |
ISO |
1 |
240,991,884 |
240,996,887 |
RGD:6480464 |
CTD |
| G |
Ppp1r3g |
protein phosphatase 1, regulatory subunit 3G |
|
decreases expression |
ISO |
17 |
35,177,316 |
35,178,359 |
RGD:6480464 |
CTD |
| G |
Ppp1r3g |
protein phosphatase 1, regulatory subunit 3G |
|
increases expression |
ISO |
17 |
35,177,316 |
35,178,359 |
RGD:6480464 |
CTD |
| G |
Ppp1r9a |
protein phosphatase 1, regulatory subunit 9A |
|
multiple interactions |
EXP |
4 |
29,654,468 |
29,928,476 |
RGD:6480464 |
CTD |
| G |
Ppp2r4 |
protein phosphatase 2A activator, regulatory subunit 4 |
|
decreases expression |
ISO |
3 |
9,461,718 |
9,492,181 |
RGD:6480464 |
CTD |
| G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isozyme |
|
decreases expression |
ISO |
2 |
234,130,176 |
234,409,232 |
RGD:6480464 |
CTD |
| G |
Pprc1 |
peroxisome proliferator-activated receptor gamma, coactivator-related 1 |
|
decreases expression |
ISO |
1 |
251,278,222 |
251,294,628 |
RGD:6480464 |
CTD |
| G |
Pqlc2 |
PQ loop repeat containing 2 |
|
multiple interactions |
ISO |
5 |
158,087,137 |
158,097,572 |
RGD:6480464 |
CTD |
| G |
Pqlc2 |
PQ loop repeat containing 2 |
|
decreases expression |
ISO |
5 |
158,087,137 |
158,097,572 |
RGD:6480464 |
CTD |
| G |
Pqlc3 |
PQ loop repeat containing 3 |
|
increases expression |
ISO |
6 |
40,676,562 |
40,688,138 |
RGD:6480464 |
CTD |
| G |
Pqlc3 |
PQ loop repeat containing 3 |
|
multiple interactions |
ISO |
6 |
40,676,562 |
40,688,138 |
RGD:6480464 |
CTD |
| G |
Prc1 |
protein regulator of cytokinesis 1 |
|
multiple interactions |
ISO |
1 |
136,112,674 |
136,133,720 |
RGD:6480464 |
CTD |
| G |
Prc1 |
protein regulator of cytokinesis 1 |
|
increases expression |
ISO |
1 |
136,112,674 |
136,133,720 |
RGD:6480464 |
CTD |
| G |
Prdm2 |
PR domain containing 2, with ZNF domain |
|
decreases expression |
ISO |
5 |
161,962,929 |
162,072,519 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
increases expression |
EXP |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
increases expression |
EXP |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prdx3 |
peroxiredoxin 3 |
|
multiple interactions |
ISO |
1 |
267,468,371 |
267,481,273 |
RGD:6480464 |
CTD |
| G |
Prdx3 |
peroxiredoxin 3 |
|
increases expression |
ISO |
1 |
267,468,371 |
267,481,273 |
RGD:6480464 |
CTD |
| G |
Prdx3 |
peroxiredoxin 3 |
|
increases expression |
EXP |
1 |
267,468,371 |
267,481,273 |
RGD:6480464 |
CTD |
| G |
Prdx6 |
peroxiredoxin 6 |
|
increases expression |
EXP |
13 |
76,824,968 |
76,835,517 |
RGD:6480464 |
CTD |
| G |
Prelid2 |
PRELI domain containing 2 |
|
increases expression |
ISO |
18 |
35,060,008 |
35,154,130 |
RGD:6480464 |
CTD |
| G |
Prelp |
proline/arginine-rich end leucine-rich repeat protein |
|
multiple interactions |
ISO |
13 |
46,863,392 |
46,874,172 |
RGD:6480464 |
CTD |
| G |
Prelp |
proline/arginine-rich end leucine-rich repeat protein |
|
decreases expression |
ISO |
13 |
46,863,392 |
46,874,172 |
RGD:6480464 |
CTD |
| G |
Prickle2 |
prickle homolog 2 (Drosophila) |
|
affects methylation |
ISO |
4 |
126,571,461 |
126,920,730 |
RGD:6480464 |
CTD |
| G |
Prickle2 |
prickle homolog 2 (Drosophila) |
|
affects methylation |
ISO |
4 |
126,571,461 |
126,920,730 |
RGD:6480464 |
CTD |
| G |
Prkag1 |
protein kinase, AMP-activated, gamma 1 non-catalytic subunit |
|
decreases expression |
EXP |
7 |
137,582,341 |
137,599,762 |
RGD:6480464 |
CTD |
| G |
Prkar1a |
protein kinase, cAMP-dependent, regulatory, type I, alpha |
|
affects expression |
ISO |
10 |
148,642,200 |
148,642,454 |
RGD:6480464 |
CTD |
| G |
Prkar1a |
protein kinase, cAMP-dependent, regulatory, type I, alpha |
|
decreases expression |
ISO |
10 |
148,642,200 |
148,642,454 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
affects expression |
ISO |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
decreases methylation |
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkch |
protein kinase C, eta |
|
decreases expression |
EXP |
6 |
96,069,354 |
96,281,790 |
RGD:6480464 |
CTD |
| G |
Prkd3 |
protein kinase D3 |
|
decreases expression |
EXP |
6 |
1,727,315 |
1,796,290 |
RGD:6480464 |
CTD |
| G |
Prkg2 |
protein kinase, cGMP-dependent, type II |
|
multiple interactions |
ISO |
14 |
11,888,101 |
12,005,547 |
RGD:6480464 |
CTD |
| G |
Prkg2 |
protein kinase, cGMP-dependent, type II |
|
increases expression |
ISO |
14 |
11,888,101 |
12,005,547 |
RGD:6480464 |
CTD |
| G |
Prlr |
prolactin receptor |
|
decreases expression |
EXP |
2 |
59,507,966 |
59,701,221 |
RGD:6480464 |
CTD |
| G |
Prmt1 |
protein arginine methyltransferase 1 |
|
increases expression |
ISO |
1 |
95,449,061 |
95,458,267 |
RGD:6480464 |
CTD |
| G |
Prmt1 |
protein arginine methyltransferase 1 |
|
increases expression |
EXP |
1 |
95,449,061 |
95,458,267 |
RGD:6480464 |
CTD |
| G |
Prmt7 |
protein arginine methyltransferase 7 |
|
increases expression |
EXP |
19 |
36,059,837 |
36,111,356 |
RGD:6480464 |
CTD |
| G |
Prodh2 |
proline dehydrogenase (oxidase) 2 |
|
multiple interactions |
ISO |
1 |
85,546,014 |
85,559,530 |
RGD:6480464 |
CTD |
| G |
Prodh2 |
proline dehydrogenase (oxidase) 2 |
|
decreases expression |
ISO |
1 |
85,546,014 |
85,559,530 |
RGD:6480464 |
CTD |
| G |
Prom1 |
prominin 1 |
|
multiple interactions |
ISO |
14 |
72,122,986 |
72,230,453 |
RGD:6480464 |
CTD |
| G |
Prom1 |
prominin 1 |
|
affects expression |
ISO |
14 |
72,122,986 |
72,230,453 |
RGD:6480464 |
CTD |
| G |
Prom1 |
prominin 1 |
|
increases expression |
ISO |
14 |
72,122,986 |
72,230,453 |
RGD:6480464 |
CTD |
| G |
Prpf6 |
PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
3 |
170,740,406 |
170,804,674 |
RGD:6480464 |
CTD |
| G |
Prps1 |
phosphoribosyl pyrophosphate synthetase 1 |
|
increases expression |
EXP |
X |
128,249,843 |
128,271,893 |
RGD:6480464 |
CTD |
| G |
Prr16 |
proline rich 16 |
|
increases expression |
ISO |
18 |
46,322,191 |
46,534,140 |
RGD:6480464 |
CTD |
| G |
Prrc2a |
proline-rich coiled-coil 2A |
|
affects expression |
ISO |
20 |
3,724,278 |
3,737,795 |
RGD:6480464 |
CTD |
| G |
Prss8 |
protease, serine, 8 |
|
affects expression |
ISO |
1 |
187,210,556 |
187,215,072 |
RGD:6480464 |
CTD |
| G |
Prss8 |
protease, serine, 8 |
|
multiple interactions |
ISO |
1 |
187,210,556 |
187,215,072 |
RGD:6480464 |
CTD |
| G |
Prss8 |
protease, serine, 8 |
|
increases expression |
ISO |
1 |
187,210,556 |
187,215,072 |
RGD:6480464 |
CTD |
| G |
Prune |
prune exopolyphosphatase |
|
multiple interactions |
ISO |
2 |
190,165,356 |
190,192,807 |
RGD:6480464 |
CTD |
| G |
Prune |
prune exopolyphosphatase |
|
increases expression |
ISO |
2 |
190,165,356 |
190,192,807 |
RGD:6480464 |
CTD |
| G |
Psen1 |
presenilin 1 |
|
increases expression |
ISO |
6 |
107,737,543 |
107,776,357 |
RGD:6480464 |
CTD |
| G |
Psen2 |
presenilin 2 |
|
increases expression |
EXP |
13 |
95,934,674 |
95,951,836 |
RGD:6480464 |
CTD |
| G |
Psma1 |
proteasome (prosome, macropain) subunit, alpha type 1 |
|
increases expression |
EXP |
1 |
172,237,763 |
172,248,782 |
RGD:6480464 |
CTD |
| G |
Psma2 |
proteasome (prosome, macropain) subunit, alpha type 2 |
|
increases expression |
EXP |
17 |
58,736,300 |
58,746,837 |
RGD:6480464 |
CTD |
| G |
Psma3 |
proteasome (prosome, macropain) subunit, alpha type 3 |
|
increases expression |
EXP |
6 |
93,092,191 |
93,112,167 |
RGD:6480464 |
CTD |
| G |
Psma4 |
proteasome (prosome, macropain) subunit, alpha type 4 |
|
increases expression |
EXP |
8 |
58,508,643 |
58,516,103 |
RGD:6480464 |
CTD |
| G |
Psma5 |
proteasome (prosome, macropain) subunit, alpha type 5 |
|
increases expression |
EXP |
2 |
203,825,060 |
203,848,378 |
RGD:6480464 |
CTD |
| G |
Psma7 |
proteasome (prosome, macropain) subunit, alpha type 7 |
|
increases expression |
EXP |
3 |
169,100,807 |
169,107,149 |
RGD:6480464 |
CTD |
| G |
Psmb1 |
proteasome (prosome, macropain) subunit, beta type 1 |
|
increases expression |
EXP |
1 |
54,369,775 |
54,388,816 |
RGD:6480464 |
CTD |
| G |
Psmb2 |
proteasome (prosome, macropain) subunit, beta type 2 |
|
increases expression |
EXP |
5 |
146,089,234 |
146,121,978 |
RGD:6480464 |
CTD |
| G |
Psmb3 |
proteasome (prosome, macropain) subunit, beta type 3 |
|
increases expression |
EXP |
10 |
86,452,533 |
86,459,616 |
RGD:6480464 |
CTD |
| G |
Psmb4 |
proteasome (prosome, macropain) subunit, beta type 4 |
|
increases expression |
EXP |
2 |
189,778,476 |
189,781,169 |
RGD:6480464 |
CTD |
| G |
Psmb5 |
proteasome (prosome, macropain) subunit, beta type 5 |
|
increases expression |
EXP |
15 |
32,689,859 |
32,694,364 |
RGD:6480464 |
CTD |
| G |
Psmb6 |
proteasome (prosome, macropain) subunit, beta type 6 |
|
increases expression |
EXP |
10 |
57,370,397 |
57,372,704 |
RGD:6480464 |
CTD |
| G |
Psmc1 |
proteasome (prosome, macropain) 26S subunit, ATPase, 1 |
|
increases expression |
EXP |
6 |
124,380,976 |
124,393,338 |
RGD:6480464 |
CTD |
| G |
Psmc2 |
proteasome (prosome, macropain) 26S subunit, ATPase 2 |
|
increases expression |
EXP |
4 |
8,704,100 |
8,718,351 |
RGD:6480464 |
CTD |
| G |
Psmc3 |
proteasome (prosome, macropain) 26S subunit, ATPase 3 |
|
increases expression |
EXP |
3 |
75,413,567 |
75,418,948 |
RGD:6480464 |
CTD |
| G |
Psmc4 |
proteasome (prosome, macropain) 26S subunit, ATPase, 4 |
|
increases expression |
EXP |
1 |
83,151,149 |
83,159,464 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
increases expression |
EXP |
10 |
95,650,987 |
95,656,921 |
RGD:6480464 |
CTD |
| G |
Psmd1 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 |
|
increases expression |
EXP |
9 |
84,807,822 |
84,882,942 |
RGD:6480464 |
CTD |
| G |
Psmd11 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
|
increases expression |
EXP |
10 |
68,664,950 |
68,710,616 |
RGD:6480464 |
CTD |
| G |
Psmd13 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 |
|
increases expression |
EXP |
1 |
201,044,403 |
201,057,026 |
RGD:6480464 |
CTD |
| G |
Psmd4 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 |
|
increases expression |
EXP |
2 |
189,933,161 |
189,942,421 |
RGD:6480464 |
CTD |
| G |
Psmd8 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 |
|
multiple interactions |
ISO |
1 |
84,308,348 |
84,315,180 |
RGD:6480464 |
CTD |
| G |
Psmd8 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 |
|
increases expression |
ISO |
1 |
84,308,348 |
84,315,180 |
RGD:6480464 |
CTD |
| G |
Psmg2 |
proteasome (prosome, macropain) assembly chaperone 2 |
|
increases expression |
ISO |
18 |
64,185,650 |
64,200,223 |
RGD:6480464 |
CTD |
| G |
Ptbp2 |
polypyrimidine tract binding protein 2 |
|
increases expression |
ISO |
2 |
216,188,745 |
216,249,176 |
RGD:6480464 |
CTD |
| G |
Ptgis |
prostaglandin I2 (prostacyclin) synthase |
|
decreases expression |
EXP |
3 |
158,356,878 |
158,387,984 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
multiple interactions |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases expression |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptms |
parathymosin |
|
decreases expression |
EXP |
4 |
161,041,242 |
161,045,145 |
RGD:6480464 |
CTD |
| G |
Ptp4a1 |
protein tyrosine phosphatase type IVA, member 1 |
|
increases expression |
EXP |
9 |
29,617,636 |
29,625,197 |
RGD:6480464 |
CTD |
| G |
Ptp4a1 |
protein tyrosine phosphatase type IVA, member 1 |
|
increases expression |
ISO |
9 |
29,617,636 |
29,625,197 |
RGD:6480464 |
CTD |
| G |
Ptplad2 |
protein tyrosine phosphatase-like A domain containing 2 |
|
multiple interactions |
ISO |
5 |
107,706,535 |
107,732,323 |
RGD:6480464 |
CTD |
| G |
Ptplad2 |
protein tyrosine phosphatase-like A domain containing 2 |
|
increases expression |
ISO |
5 |
107,706,535 |
107,732,323 |
RGD:6480464 |
CTD |
| G |
Ptplb |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b |
|
multiple interactions |
ISO |
11 |
67,489,819 |
67,581,576 |
RGD:6480464 |
CTD |
| G |
Ptplb |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b |
|
increases expression |
ISO |
11 |
67,489,819 |
67,581,576 |
RGD:6480464 |
CTD |
| G |
Ptpn21 |
protein tyrosine phosphatase, non-receptor type 21 |
|
increases expression |
EXP |
6 |
122,840,062 |
122,910,939 |
RGD:6480464 |
CTD |
| G |
Ptpn9 |
protein tyrosine phosphatase, non-receptor type 9 |
|
decreases expression |
ISO |
8 |
60,737,741 |
60,817,948 |
RGD:6480464 |
CTD |
| G |
Ptprb |
protein tyrosine phosphatase, receptor type, B |
|
multiple interactions |
ISO |
7 |
55,613,557 |
55,714,216 |
RGD:6480464 |
CTD |
| G |
Ptprb |
protein tyrosine phosphatase, receptor type, B |
|
decreases expression |
ISO |
7 |
55,613,557 |
55,714,216 |
RGD:6480464 |
CTD |
| G |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
|
increases expression |
EXP |
5 |
94,069,724 |
94,286,657 |
RGD:6480464 |
CTD |
| G |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
|
affects methylation |
ISO |
4 |
174,376,396 |
174,586,694 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
multiple interactions |
ISO |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
increases expression |
ISO |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
PVR |
poliovirus receptor |
|
increases expression |
EXP |
1 |
79,213,654 |
79,229,063 |
RGD:6480464 |
CTD |
| G |
Pxmp4 |
peroxisomal membrane protein 4 |
|
decreases expression |
ISO |
3 |
145,061,123 |
145,078,370 |
RGD:6480464 |
CTD |
| G |
Pygb |
phosphorylase, glycogen; brain |
|
multiple interactions |
ISO |
3 |
141,421,421 |
141,468,094 |
RGD:6480464 |
CTD |
| G |
Pygb |
phosphorylase, glycogen; brain |
|
increases expression |
ISO |
3 |
141,421,421 |
141,468,094 |
RGD:6480464 |
CTD |
| G |
Rab18 |
RAB18, member RAS oncogene family |
|
increases expression |
ISO |
17 |
63,497,924 |
63,529,233 |
RGD:6480464 |
CTD |
| G |
Rab33a |
RAB33A, member RAS oncogene family |
|
multiple interactions |
ISO |
X |
134,913,903 |
134,925,308 |
RGD:6480464 |
CTD |
| G |
Rab33a |
RAB33A, member RAS oncogene family |
|
increases expression |
ISO |
X |
134,913,903 |
134,925,308 |
RGD:6480464 |
CTD |
| G |
Rab4b |
RAB4B, member RAS oncogene family |
|
increases expression |
EXP |
1 |
82,242,920 |
82,254,443 |
RGD:6480464 |
CTD |
| G |
Rab5a |
RAB5A, member RAS oncogene family |
|
affects expression |
ISO |
9 |
1,492,864 |
1,516,405 |
RGD:6480464 |
CTD |
| G |
Racgap1 |
Rac GTPase-activating protein 1 |
|
multiple interactions |
ISO |
7 |
138,366,356 |
138,395,716 |
RGD:6480464 |
CTD |
| G |
Racgap1 |
Rac GTPase-activating protein 1 |
|
increases expression |
ISO |
7 |
138,366,356 |
138,395,716 |
RGD:6480464 |
CTD |
| G |
Rad1 |
RAD1 homolog (S. pombe) |
|
affects expression |
ISO |
2 |
59,837,934 |
59,845,973 |
RGD:6480464 |
CTD |
| G |
Rad51 |
RAD51 homolog (S. cerevisiae) |
|
increases expression |
ISO |
3 |
105,625,265 |
105,650,392 |
RGD:6480464 |
CTD |
| G |
Rad51 |
RAD51 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
3 |
105,625,265 |
105,650,392 |
RGD:6480464 |
CTD |
| G |
Rad51b |
RAD51 homolog B (S. cerevisiae) |
|
increases expression |
ISO |
6 |
102,069,799 |
102,134,176 |
RGD:6480464 |
CTD |
| G |
Rad51b |
RAD51 homolog B (S. cerevisiae) |
|
multiple interactions |
ISO |
6 |
102,069,799 |
102,134,176 |
RGD:6480464 |
CTD |
| G |
Rasl11b |
RAS-like family 11 member B |
|
increases expression |
ISO |
14 |
36,392,945 |
36,397,168 |
RGD:6480464 |
CTD |
| G |
Rassf5 |
Ras association (RalGDS/AF-6) domain family member 5 |
|
increases expression |
ISO |
13 |
44,121,863 |
44,188,493 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases expression |
EXP |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbbp8 |
retinoblastoma binding protein 8 |
|
multiple interactions |
ISO |
18 |
3,266,565 |
3,333,153 |
RGD:6480464 |
CTD |
| G |
Rbbp8 |
retinoblastoma binding protein 8 |
|
increases expression |
ISO |
18 |
3,266,565 |
3,333,153 |
RGD:6480464 |
CTD |
| G |
Rbl1 |
retinoblastoma-like 1 (p107) |
|
increases expression |
ISO |
3 |
147,734,622 |
147,796,630 |
RGD:6480464 |
CTD |
| G |
Rbl1 |
retinoblastoma-like 1 (p107) |
|
multiple interactions |
ISO |
3 |
147,734,622 |
147,796,630 |
RGD:6480464 |
CTD |
| G |
Rbm12b |
RNA binding motif protein 12B |
|
increases expression |
ISO |
5 |
26,382,356 |
26,385,470 |
RGD:6480464 |
CTD |
| G |
Rbm24 |
RNA binding motif protein 24 |
|
multiple interactions |
ISO |
17 |
24,217,930 |
24,229,736 |
RGD:6480464 |
CTD |
| G |
Rbm24 |
RNA binding motif protein 24 |
|
increases expression |
ISO |
17 |
24,217,930 |
24,229,736 |
RGD:6480464 |
CTD |
| G |
Rbm43 |
RNA binding motif protein 43 |
|
increases expression |
ISO |
3 |
32,938,135 |
32,958,882 |
RGD:6480464 |
CTD |
| G |
Rbm43 |
RNA binding motif protein 43 |
|
multiple interactions |
ISO |
3 |
32,938,135 |
32,958,882 |
RGD:6480464 |
CTD |
| G |
Rbm47 |
RNA binding motif protein 47 |
|
increases expression |
ISO |
14 |
44,815,888 |
44,846,231 |
RGD:6480464 |
CTD |
| G |
Rbm47 |
RNA binding motif protein 47 |
|
decreases expression |
ISO |
14 |
44,815,888 |
44,846,231 |
RGD:6480464 |
CTD |
| G |
Rbm47 |
RNA binding motif protein 47 |
|
multiple interactions |
ISO |
14 |
44,815,888 |
44,846,231 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
multiple interactions |
ISO |
8 |
103,605,870 |
103,627,390 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
increases expression |
ISO |
8 |
103,605,870 |
103,627,390 |
RGD:6480464 |
CTD |
| G |
Rcan1 |
regulator of calcineurin 1 |
|
decreases expression |
ISO |
11 |
32,386,576 |
32,408,850 |
RGD:6480464 |
CTD |
| G |
Rcan2 |
regulator of calcineurin 2 |
|
multiple interactions |
ISO |
9 |
12,623,121 |
12,853,302 |
RGD:6480464 |
CTD |
| G |
Rcan2 |
regulator of calcineurin 2 |
|
increases expression |
ISO |
9 |
12,623,121 |
12,853,302 |
RGD:6480464 |
CTD |
| G |
Rce1 |
RCE1 homolog, prenyl protein protease (S. cerevisiae) |
|
multiple interactions |
ISO |
1 |
207,213,714 |
207,216,814 |
RGD:6480464 |
CTD |
| G |
Rce1 |
RCE1 homolog, prenyl protein protease (S. cerevisiae) |
|
increases expression |
ISO |
1 |
207,213,714 |
207,216,814 |
RGD:6480464 |
CTD |
| G |
Rcor1 |
REST corepressor 1 |
|
decreases expression |
ISO |
6 |
135,859,305 |
135,862,320 |
RGD:6480464 |
CTD |
| G |
Rec8 |
REC8 homolog (yeast) |
|
multiple interactions |
ISO |
15 |
33,753,772 |
33,761,237 |
RGD:6480464 |
CTD |
| G |
Rec8 |
REC8 homolog (yeast) |
|
increases expression |
ISO |
15 |
33,753,772 |
33,761,237 |
RGD:6480464 |
CTD |
| G |
Reep1 |
receptor accessory protein 1 |
|
multiple interactions |
ISO |
4 |
104,982,925 |
105,099,852 |
RGD:6480464 |
CTD |
| G |
Reep1 |
receptor accessory protein 1 |
|
increases expression |
ISO |
4 |
104,982,925 |
105,099,852 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rell1 |
RELT-like 1 |
|
multiple interactions |
ISO |
14 |
47,179,973 |
47,229,627 |
RGD:6480464 |
CTD |
| G |
Rell1 |
RELT-like 1 |
|
decreases expression |
ISO |
14 |
47,179,973 |
47,229,627 |
RGD:6480464 |
CTD |
| G |
Rell1 |
RELT-like 1 |
|
increases expression |
ISO |
14 |
47,179,973 |
47,229,627 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
multiple interactions |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
decreases expression |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Reps1 |
RALBP1 associated Eps domain containing 1 |
|
multiple interactions |
ISO |
1 |
13,106,941 |
13,185,314 |
RGD:6480464 |
CTD |
| G |
Reps1 |
RALBP1 associated Eps domain containing 1 |
|
increases expression |
ISO |
1 |
13,106,941 |
13,185,314 |
RGD:6480464 |
CTD |
| G |
Rer1 |
RER1 retention in endoplasmic reticulum 1 homolog (S. cerevisiae) |
|
affects expression |
ISO |
5 |
171,875,696 |
171,887,772 |
RGD:6480464 |
CTD |
| G |
Rerg |
RAS-like, estrogen-regulated, growth-inhibitor |
|
decreases expression |
ISO |
4 |
174,125,313 |
174,140,346 |
RGD:6480464 |
CTD |
| G |
Rerg |
RAS-like, estrogen-regulated, growth-inhibitor |
|
multiple interactions |
ISO |
4 |
174,125,313 |
174,140,346 |
RGD:6480464 |
CTD |
| G |
Retnla |
resistin like alpha |
|
decreases expression |
ISO |
11 |
53,205,246 |
53,206,745 |
RGD:6480464 |
CTD |
| G |
Retsat |
retinol saturase (all trans retinol 13,14 reductase) |
|
multiple interactions |
ISO |
4 |
106,100,103 |
106,108,866 |
RGD:6480464 |
CTD |
| G |
Retsat |
retinol saturase (all trans retinol 13,14 reductase) |
|
decreases expression |
ISO |
4 |
106,100,103 |
106,108,866 |
RGD:6480464 |
CTD |
| G |
Rev1 |
REV1, polymerase (DNA directed) |
|
increases expression |
ISO |
9 |
36,994,269 |
37,042,663 |
RGD:6480464 |
CTD |
| G |
Rfng |
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
RGD1562284 |
similar to Glutaminyl-peptide cyclotransferase precursor (QC) |
|
increases expression |
EXP |
6 |
1,845,425 |
1,878,423 |
RGD:6480464 |
CTD |
| G |
Rgl3 |
ral guanine nucleotide dissociation stimulator-like 3 |
|
increases expression |
ISO |
8 |
21,072,473 |
21,092,569 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin (senescence marker protein-30) |
|
decreases expression |
EXP |
X |
13,037,171 |
13,052,846 |
RGD:6480464 |
CTD |
| G |
Rgs16 |
regulator of G-protein signaling 16 |
|
decreases expression |
ISO |
13 |
68,807,863 |
68,811,307 |
RGD:6480464 |
CTD |
| G |
Rgs16 |
regulator of G-protein signaling 16 |
|
multiple interactions |
ISO |
13 |
68,807,863 |
68,811,307 |
RGD:6480464 |
CTD |
| G |
Rgs16 |
regulator of G-protein signaling 16 |
|
increases expression |
ISO |
13 |
68,807,863 |
68,811,307 |
RGD:6480464 |
CTD |
| G |
Rgs3 |
regulator of G-protein signaling 3 |
|
increases expression |
ISO |
5 |
79,624,388 |
79,709,035 |
RGD:6480464 |
CTD |
| G |
Rhbdf1 |
rhomboid 5 homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
10 |
15,653,948 |
15,666,851 |
RGD:6480464 |
CTD |
| G |
Rhbdf1 |
rhomboid 5 homolog 1 (Drosophila) |
|
increases expression |
ISO |
10 |
15,653,948 |
15,666,851 |
RGD:6480464 |
CTD |
| G |
Rhbdf2 |
rhomboid 5 homolog 2 (Drosophila) |
|
multiple interactions |
ISO |
10 |
106,715,043 |
106,742,198 |
RGD:6480464 |
CTD |
| G |
Rhbdf2 |
rhomboid 5 homolog 2 (Drosophila) |
|
increases expression |
ISO |
10 |
106,715,043 |
106,742,198 |
RGD:6480464 |
CTD |
| G |
Rhbg |
Rh family, B glycoprotein |
|
multiple interactions |
ISO |
2 |
180,320,787 |
180,333,050 |
RGD:6480464 |
CTD |
| G |
Rhbg |
Rh family, B glycoprotein |
|
increases expression |
ISO |
2 |
180,320,787 |
180,333,050 |
RGD:6480464 |
CTD |
| G |
Rhob |
ras homolog family member B |
|
increases expression |
EXP |
6 |
32,052,333 |
32,054,507 |
RGD:6480464 |
CTD |
| G |
Rhpn2 |
rhophilin, Rho GTPase binding protein 2 |
|
multiple interactions |
ISO |
1 |
87,853,620 |
87,917,634 |
RGD:6480464 |
CTD |
| G |
Rhpn2 |
rhophilin, Rho GTPase binding protein 2 |
|
increases expression |
ISO |
1 |
87,853,620 |
87,917,634 |
RGD:6480464 |
CTD |
| G |
Rnase4 |
ribonuclease, RNase A family 4 |
|
decreases expression |
EXP |
15 |
27,073,756 |
27,090,441 |
RGD:6480464 |
CTD |
| G |
Rnd3 |
Rho family GTPase 3 |
|
increases expression |
ISO |
3 |
32,101,433 |
32,118,785 |
RGD:6480464 |
CTD |
| G |
Rnf13 |
ring finger protein 13 |
|
increases expression |
ISO |
2 |
146,995,576 |
147,061,229 |
RGD:6480464 |
CTD |
| G |
Rnf145 |
ring finger protein 145 |
|
multiple interactions |
ISO |
10 |
29,680,833 |
29,720,064 |
RGD:6480464 |
CTD |
| G |
Rnf145 |
ring finger protein 145 |
|
increases expression |
ISO |
10 |
29,680,833 |
29,720,064 |
RGD:6480464 |
CTD |
| G |
Rnf19b |
ring finger protein 19B |
|
increases expression |
ISO |
5 |
148,230,183 |
148,243,398 |
RGD:6480464 |
CTD |
| G |
Rnpep |
arginyl aminopeptidase (aminopeptidase B) |
|
multiple interactions |
ISO |
13 |
48,267,923 |
48,286,295 |
RGD:6480464 |
CTD |
| G |
Rnpep |
arginyl aminopeptidase (aminopeptidase B) |
|
increases expression |
ISO |
13 |
48,267,923 |
48,286,295 |
RGD:6480464 |
CTD |
| G |
Rnps1 |
ribonucleic acid binding protein S1 |
|
increases expression |
ISO |
10 |
13,670,753 |
13,681,591 |
RGD:6480464 |
CTD |
| G |
Robo1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
|
increases expression |
ISO |
11 |
10,784,947 |
11,720,646 |
RGD:6480464 |
CTD |
| G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
|
decreases expression |
ISO |
18 |
1,391,751 |
1,511,865 |
RGD:6480464 |
CTD |
| G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
|
multiple interactions |
ISO |
6 |
40,581,247 |
40,672,854 |
RGD:6480464 |
CTD |
| G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
|
increases expression |
ISO |
6 |
40,581,247 |
40,672,854 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor A |
|
increases expression |
ISO |
8 |
73,052,282 |
73,817,764 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor A |
|
increases expression |
ISO |
8 |
73,052,282 |
73,817,764 |
RGD:6480464 |
CTD |
| G |
Rpa1 |
replication protein A1 |
|
multiple interactions |
ISO |
10 |
62,613,169 |
62,656,565 |
RGD:6480464 |
CTD |
| G |
Rpa1 |
replication protein A1 |
|
increases expression |
ISO |
10 |
62,613,169 |
62,656,565 |
RGD:6480464 |
CTD |
| G |
Rpl13a |
ribosomal protein L13A |
|
decreases expression |
ISO |
1 |
95,600,814 |
95,603,504 |
RGD:6480464 |
CTD |
| G |
Rraga |
Ras-related GTP binding A |
|
increases expression |
ISO |
5 |
105,659,659 |
105,661,254 |
RGD:6480464 |
CTD |
| G |
Rras |
related RAS viral (r-ras) oncogene homolog |
|
multiple interactions |
ISO |
1 |
95,490,730 |
95,495,462 |
RGD:6480464 |
CTD |
| G |
Rras |
related RAS viral (r-ras) oncogene homolog |
|
increases expression |
ISO |
1 |
95,490,730 |
95,495,462 |
RGD:6480464 |
CTD |
| G |
Rrm1-ps1 |
ribonucleotide reductase M1, pseudogene 1 |
|
affects expression |
ISO |
14 |
77,408,781 |
77,411,150 |
RGD:6480464 |
CTD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
multiple interactions |
ISO |
6 |
42,350,541 |
42,356,748 |
RGD:6480464 |
CTD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
increases expression |
ISO |
6 |
42,350,541 |
42,356,748 |
RGD:6480464 |
CTD |
| G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
|
multiple interactions |
ISO |
6 |
44,100,775 |
44,113,910 |
RGD:6480464 |
CTD |
| G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
|
increases expression |
ISO |
6 |
44,100,775 |
44,113,910 |
RGD:6480464 |
CTD |
| G |
Rsbn1 |
round spermatid basic protein 1 |
|
affects expression |
ISO |
2 |
199,146,161 |
199,200,110 |
RGD:6480464 |
CTD |
| G |
Rspo3 |
R-spondin 3 |
|
multiple interactions |
ISO |
1 |
29,072,171 |
29,156,096 |
RGD:6480464 |
CTD |
| G |
Rspo3 |
R-spondin 3 |
|
decreases expression |
ISO |
1 |
29,072,171 |
29,156,096 |
RGD:6480464 |
CTD |
| G |
RT1-Bb |
RT1 class II, locus Bb |
|
decreases expression |
EXP |
20 |
4,730,559 |
4,736,201 |
RGD:6480464 |
CTD |
| G |
RT1-Cl |
RT1 class Ib, locus Cl |
|
decreases expression |
EXP |
20 |
2,116,560 |
2,134,175 |
RGD:6480464 |
CTD |
| G |
RT1-EC2 |
RT1 class Ib, locus EC2 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
RT1-S3 |
RT1 class Ib, locus S3 |
|
decreases expression |
EXP |
20 |
2,815,943 |
2,820,644 |
RGD:6480464 |
CTD |
| G |
Rtkn |
rhotekin |
|
increases expression |
ISO |
4 |
117,348,330 |
117,363,967 |
RGD:6480464 |
CTD |
| G |
Rtkn |
rhotekin |
|
multiple interactions |
ISO |
4 |
117,348,330 |
117,363,967 |
RGD:6480464 |
CTD |
| G |
Rtn4rl1 |
reticulon 4 receptor-like 1 |
|
decreases expression |
ISO |
10 |
62,500,853 |
62,576,593 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
affects expression |
EXP |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
S100a10 |
S100 calcium binding protein A10 |
|
multiple interactions |
ISO |
2 |
186,645,674 |
186,654,321 |
RGD:6480464 |
CTD |
| G |
S100a10 |
S100 calcium binding protein A10 |
|
increases expression |
ISO |
2 |
186,645,674 |
186,654,321 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
increases expression |
ISO |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
multiple interactions |
ISO |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
increases expression |
ISO |
2 |
211,851,304 |
211,855,511 |
RGD:6480464 |
CTD |
| G |
S1pr5 |
sphingosine-1-phosphate receptor 5 |
|
multiple interactions |
ISO |
8 |
20,278,404 |
20,283,375 |
RGD:6480464 |
CTD |
| G |
S1pr5 |
sphingosine-1-phosphate receptor 5 |
|
decreases expression |
ISO |
8 |
20,278,404 |
20,283,375 |
RGD:6480464 |
CTD |
| G |
Saa4 |
serum amyloid A4, constitutive |
|
increases expression |
ISO |
1 |
97,278,427 |
97,282,729 |
RGD:6480464 |
CTD |
| G |
Sbk1 |
SH3-binding domain kinase 1 |
|
increases expression |
ISO |
1 |
185,344,267 |
185,366,109 |
RGD:6480464 |
CTD |
| G |
Scamp1 |
secretory carrier membrane protein 1 |
|
increases expression |
ISO |
2 |
24,495,965 |
24,586,869 |
RGD:6480464 |
CTD |
| G |
Scamp5 |
secretory carrier membrane protein 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Scamp5 |
secretory carrier membrane protein 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Scgb1d2 |
secretoglobin, family 1D, member 2 |
|
increases expression |
EXP |
1 |
212,016,491 |
212,019,480 |
RGD:6480464 |
CTD |
| G |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
|
increases expression |
EXP |
4 |
161,445,936 |
161,469,267 |
RGD:6480464 |
CTD |
| G |
Sdc1 |
syndecan 1 |
|
decreases expression |
ISO |
6 |
32,253,352 |
32,275,812 |
RGD:6480464 |
CTD |
| G |
Sdc1 |
syndecan 1 |
|
decreases expression |
EXP |
6 |
32,253,352 |
32,275,812 |
RGD:6480464 |
CTD |
| G |
Sdc4 |
syndecan 4 |
|
increases expression |
EXP |
3 |
155,446,138 |
155,464,825 |
RGD:6480464 |
CTD |
| G |
Sdr9c7 |
short chain dehydrogenase/reductase family 9C, member 7 |
|
multiple interactions |
ISO |
7 |
67,850,985 |
67,863,306 |
RGD:6480464 |
CTD |
| G |
Sdr9c7 |
short chain dehydrogenase/reductase family 9C, member 7 |
|
decreases expression |
ISO |
7 |
67,850,985 |
67,863,306 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
multiple interactions |
ISO |
12 |
37,281,091 |
37,288,403 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
decreases expression |
ISO |
12 |
37,281,091 |
37,288,403 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
increases expression |
ISO |
12 |
37,281,091 |
37,288,403 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
affects expression |
EXP |
12 |
37,281,091 |
37,288,403 |
RGD:6480464 |
CTD |
| G |
Sdsl |
serine dehydratase-like |
|
decreases expression |
ISO |
12 |
37,297,342 |
37,307,847 |
RGD:6480464 |
CTD |
| G |
Sdsl |
serine dehydratase-like |
|
multiple interactions |
ISO |
12 |
37,297,342 |
37,307,847 |
RGD:6480464 |
CTD |
| G |
Sec62 |
SEC62 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
2 |
116,990,256 |
117,025,688 |
RGD:6480464 |
CTD |
| G |
Sectm1 |
secreted and transmembrane 1 |
|
multiple interactions |
ISO |
10 |
110,283,747 |
110,294,733 |
RGD:6480464 |
CTD |
| G |
Sectm1 |
secreted and transmembrane 1 |
|
increases expression |
ISO |
10 |
110,283,747 |
110,294,733 |
RGD:6480464 |
CTD |
| G |
Sema3b |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
|
increases expression |
ISO |
8 |
112,845,709 |
112,852,565 |
RGD:6480464 |
CTD |
| G |
Sema3b |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
|
multiple interactions |
ISO |
8 |
112,845,709 |
112,852,565 |
RGD:6480464 |
CTD |
| G |
Senp3 |
Sumo1/sentrin/SMT3 specific peptidase 3 |
|
decreases expression |
EXP |
10 |
56,490,584 |
56,499,367 |
RGD:6480464 |
CTD |
| G |
Sephs2 |
selenophosphate synthetase 2 |
|
decreases expression |
ISO |
1 |
186,535,717 |
186,538,035 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
decreases expression |
EXP |
2 |
52,451,883 |
52,462,263 |
RGD:6480464 |
CTD |
| G |
Sept9 |
septin 9 |
|
multiple interactions |
EXP |
10 |
107,343,672 |
107,479,964 |
RGD:6480464 |
CTD |
| G |
Serinc1 |
serine incorporator 1 |
|
increases expression |
ISO |
20 |
36,541,193 |
36,560,101 |
RGD:6480464 |
CTD |
| G |
Serinc5 |
serine incorporator 5 |
|
increases expression |
ISO |
2 |
22,871,987 |
22,977,705 |
RGD:6480464 |
CTD |
| G |
Serp1 |
stress-associated endoplasmic reticulum protein 1 |
|
increases expression |
EXP |
2 |
147,866,072 |
147,870,096 |
RGD:6480464 |
CTD |
| G |
Serpina11 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 |
|
multiple interactions |
ISO |
6 |
128,036,623 |
128,046,046 |
RGD:6480464 |
CTD |
| G |
Serpina11 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 |
|
decreases expression |
ISO |
6 |
128,036,623 |
128,046,046 |
RGD:6480464 |
CTD |
| G |
Serpina12 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 |
|
multiple interactions |
ISO |
6 |
128,086,068 |
128,100,843 |
RGD:6480464 |
CTD |
| G |
Serpina12 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 |
|
decreases expression |
ISO |
6 |
128,086,068 |
128,100,843 |
RGD:6480464 |
CTD |
| G |
Serpina3m |
serine (or cysteine) proteinase inhibitor, clade A, member 3M |
|
multiple interactions |
ISO |
6 |
128,197,796 |
128,205,050 |
RGD:6480464 |
CTD |
| G |
Serpina3m |
serine (or cysteine) proteinase inhibitor, clade A, member 3M |
|
decreases expression |
ISO |
6 |
128,197,796 |
128,205,050 |
RGD:6480464 |
CTD |
| G |
Serpina4 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 |
|
affects expression |
ISO |
6 |
128,133,692 |
128,142,768 |
RGD:6480464 |
CTD |
| G |
Serpina4 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 |
|
decreases expression |
ISO |
6 |
128,133,692 |
128,142,768 |
RGD:6480464 |
CTD |
| G |
Serpina7 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
|
decreases expression |
EXP |
X |
126,739,203 |
126,744,763 |
RGD:6480464 |
CTD |
| G |
Serpina9 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9 |
|
multiple interactions |
ISO |
6 |
128,052,256 |
128,069,518 |
RGD:6480464 |
CTD |
| G |
Serpina9 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9 |
|
decreases expression |
ISO |
6 |
128,052,256 |
128,069,518 |
RGD:6480464 |
CTD |
| G |
Serpinb1a |
serine (or cysteine) proteinase inhibitor, clade B, member 1a |
|
increases expression |
ISO |
17 |
37,950,875 |
37,959,284 |
RGD:6480464 |
CTD |
| G |
Serpinb6b |
serine (or cysteine) peptidase inhibitor, clade B, member 6b |
|
increases expression |
ISO |
17 |
37,816,548 |
37,834,299 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
decreases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine2 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
|
multiple interactions |
ISO |
9 |
79,091,414 |
79,166,330 |
RGD:6480464 |
CTD |
| G |
Serpine2 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
|
decreases expression |
ISO |
9 |
79,091,414 |
79,166,330 |
RGD:6480464 |
CTD |
| G |
Sertad1 |
SERTA domain containing 1 |
|
decreases expression |
ISO |
1 |
82,565,982 |
82,569,250 |
RGD:6480464 |
CTD |
| G |
Sesn1 |
sestrin 1 |
|
increases expression |
ISO |
20 |
45,786,623 |
45,877,856 |
RGD:6480464 |
CTD |
| G |
Setd4 |
SET domain containing 4 |
|
increases expression |
ISO |
11 |
33,765,399 |
33,785,529 |
RGD:6480464 |
CTD |
| G |
Sfpq |
splicing factor proline/glutamine-rich |
|
decreases expression |
EXP |
5 |
146,460,306 |
146,469,289 |
RGD:6480464 |
CTD |
| G |
Sfxn1 |
sideroflexin 1 |
|
multiple interactions |
ISO |
17 |
16,601,066 |
16,636,502 |
RGD:6480464 |
CTD |
| G |
Sfxn1 |
sideroflexin 1 |
|
decreases expression |
ISO |
17 |
16,601,066 |
16,636,502 |
RGD:6480464 |
CTD |
| G |
Sfxn5 |
sideroflexin 5 |
|
multiple interactions |
ISO |
4 |
119,462,697 |
119,583,363 |
RGD:6480464 |
CTD |
| G |
Sfxn5 |
sideroflexin 5 |
|
decreases expression |
ISO |
4 |
119,462,697 |
119,583,363 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
decreases expression |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Sgms1 |
sphingomyelin synthase 1 |
|
multiple interactions |
ISO |
1 |
236,133,441 |
236,396,631 |
RGD:6480464 |
CTD |
| G |
Sgms1 |
sphingomyelin synthase 1 |
|
increases expression |
ISO |
1 |
236,133,441 |
236,396,631 |
RGD:6480464 |
CTD |
| G |
Sgol1 |
shugoshin-like 1 (S. pombe) |
|
multiple interactions |
ISO |
9 |
863,665 |
876,405 |
RGD:6480464 |
CTD |
| G |
Sgol1 |
shugoshin-like 1 (S. pombe) |
|
increases expression |
ISO |
9 |
863,665 |
876,405 |
RGD:6480464 |
CTD |
| G |
Sgol2 |
shugoshin-like 2 (S. pombe) |
|
increases expression |
ISO |
9 |
56,664,634 |
56,681,534 |
RGD:6480464 |
CTD |
| G |
Sgol2 |
shugoshin-like 2 (S. pombe) |
|
multiple interactions |
ISO |
9 |
56,664,634 |
56,681,534 |
RGD:6480464 |
CTD |
| G |
Sgpl1 |
sphingosine-1-phosphate lyase 1 |
|
increases expression |
ISO |
20 |
28,459,734 |
28,505,017 |
RGD:6480464 |
CTD |
| G |
Sh2d4a |
SH2 domain containing 4A |
|
increases expression |
ISO |
16 |
22,957,569 |
23,027,864 |
RGD:6480464 |
CTD |
| G |
Sh2d4a |
SH2 domain containing 4A |
|
affects expression |
ISO |
16 |
22,957,569 |
23,027,864 |
RGD:6480464 |
CTD |
| G |
Sh3bp2 |
SH3-domain binding protein 2 |
|
increases expression |
ISO |
14 |
81,818,728 |
81,855,875 |
RGD:6480464 |
CTD |
| G |
Sh3gl3 |
SH3-domain GRB2-like 3 |
|
decreases expression |
EXP |
1 |
138,398,336 |
138,529,056 |
RGD:6480464 |
CTD |
| G |
Shc1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
increases expression |
ISO |
2 |
181,616,581 |
181,628,144 |
RGD:6480464 |
CTD |
| G |
Shcbp1 |
Shc SH2-domain binding protein 1 |
|
multiple interactions |
ISO |
16 |
90,002,645 |
90,022,167 |
RGD:6480464 |
CTD |
| G |
Shcbp1 |
Shc SH2-domain binding protein 1 |
|
increases expression |
ISO |
16 |
90,002,645 |
90,022,167 |
RGD:6480464 |
CTD |
| G |
Shf |
Src homology 2 domain containing F |
|
multiple interactions |
ISO |
3 |
109,129,634 |
109,169,928 |
RGD:6480464 |
CTD |
| G |
Shf |
Src homology 2 domain containing F |
|
increases expression |
ISO |
3 |
109,129,634 |
109,169,928 |
RGD:6480464 |
CTD |
| G |
Shmt1 |
serine hydroxymethyltransferase 1 (soluble) |
|
increases expression |
ISO |
10 |
46,936,605 |
46,964,779 |
RGD:6480464 |
CTD |
| G |
Shoc2 |
soc-2 (suppressor of clear) homolog (C. elegans) |
|
affects expression |
ISO |
1 |
260,255,253 |
260,273,170 |
RGD:6480464 |
CTD |
| G |
Shroom1 |
shroom family member 1 |
|
increases expression |
ISO |
10 |
38,925,114 |
38,935,035 |
RGD:6480464 |
CTD |
| G |
Sidt1 |
SID1 transmembrane family, member 1 |
|
increases expression |
ISO |
11 |
57,926,982 |
58,024,032 |
RGD:6480464 |
CTD |
| G |
Sidt1 |
SID1 transmembrane family, member 1 |
|
multiple interactions |
ISO |
11 |
57,926,982 |
58,024,032 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
affects expression |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Siva1 |
SIVA1, apoptosis-inducing factor |
|
increases expression |
ISO |
6 |
137,631,408 |
137,635,724 |
RGD:6480464 |
CTD |
| G |
Siva1 |
SIVA1, apoptosis-inducing factor |
|
multiple interactions |
ISO |
6 |
137,631,408 |
137,635,724 |
RGD:6480464 |
CTD |
| G |
Six3 |
SIX homeobox 3 |
|
affects methylation |
ISO |
6 |
8,981,995 |
9,019,365 |
RGD:6480464 |
CTD |
| G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
|
decreases expression |
ISO |
6 |
104,735,839 |
104,749,464 |
RGD:6480464 |
CTD |
| G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
|
decreases expression |
EXP |
6 |
104,735,839 |
104,749,464 |
RGD:6480464 |
CTD |
| G |
Slc10a2 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 2 |
|
increases expression |
ISO |
16 |
89,939,295 |
89,961,444 |
RGD:6480464 |
CTD |
| G |
Slc10a2 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 2 |
|
multiple interactions |
ISO |
16 |
89,939,295 |
89,961,444 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
decreases methylation |
ISO |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
ISO |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
decreases methylation |
ISO |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc12a2 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
|
multiple interactions |
ISO |
18 |
53,673,215 |
53,741,352 |
RGD:6480464 |
CTD |
| G |
Slc12a2 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
|
decreases expression |
ISO |
18 |
53,673,215 |
53,741,352 |
RGD:6480464 |
CTD |
| G |
Slc13a2 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
|
multiple interactions |
ISO |
10 |
64,503,787 |
64,531,097 |
RGD:6480464 |
CTD |
| G |
Slc13a2 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
|
increases expression |
ISO |
10 |
64,503,787 |
64,531,097 |
RGD:6480464 |
CTD |
| G |
Slc13a3 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 |
|
multiple interactions |
ISO |
3 |
156,447,900 |
156,510,620 |
RGD:6480464 |
CTD |
| G |
Slc13a3 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 |
|
increases expression |
ISO |
3 |
156,447,900 |
156,510,620 |
RGD:6480464 |
CTD |
| G |
Slc15a4 |
solute carrier family 15, member 4 |
|
increases expression |
ISO |
12 |
30,111,863 |
30,131,134 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
decreases expression |
EXP |
2 |
199,860,341 |
199,879,856 |
RGD:6480464 |
CTD |
| G |
Slc16a12 |
solute carrier family 16, member 12 (monocarboxylic acid transporter 12) |
|
increases expression |
ISO |
1 |
238,643,040 |
238,665,699 |
RGD:6480464 |
CTD |
| G |
Slc16a7 |
solute carrier family 16, member 7 (monocarboxylic acid transporter 2) |
|
multiple interactions |
ISO |
7 |
65,210,148 |
65,313,572 |
RGD:6480464 |
CTD |
| G |
Slc16a7 |
solute carrier family 16, member 7 (monocarboxylic acid transporter 2) |
|
increases expression |
ISO |
7 |
65,210,148 |
65,313,572 |
RGD:6480464 |
CTD |
| G |
Slc17a2 |
solute carrier family 17 (sodium phosphate), member 2 |
|
decreases expression |
ISO |
17 |
48,557,119 |
48,573,741 |
RGD:6480464 |
CTD |
| G |
Slc17a2 |
solute carrier family 17 (sodium phosphate), member 2 |
|
multiple interactions |
ISO |
17 |
48,557,119 |
48,573,741 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
multiple interactions |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
decreases activity |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
increases expression |
ISO |
1 |
232,469,746 |
232,549,584 |
RGD:6480464 |
CTD |
| G |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
multiple interactions |
ISO |
1 |
232,469,746 |
232,549,584 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
multiple interactions |
ISO |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
increases expression |
ISO |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc20a1 |
solute carrier family 20 (phosphate transporter), member 1 |
|
multiple interactions |
ISO |
3 |
116,813,990 |
116,828,049 |
RGD:6480464 |
CTD |
| G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
|
decreases expression |
EXP |
9 |
9,934,309 |
9,940,107 |
RGD:6480464 |
CTD |
| G |
Slc23a1 |
solute carrier family 23 (nucleobase transporters), member 1 |
|
increases expression |
ISO |
18 |
28,238,953 |
28,250,889 |
RGD:6480464 |
CTD |
| G |
Slc25a15 |
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15 |
|
increases expression |
ISO |
16 |
74,280,827 |
74,301,105 |
RGD:6480464 |
CTD |
| G |
Slc25a17 |
solute carrier family 25 (mitochondrial carrier, peroxisomal membrane protein), member 17 |
|
increases expression |
ISO |
7 |
119,645,403 |
119,690,130 |
RGD:6480464 |
CTD |
| G |
Slc25a20 |
solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
|
increases expression |
EXP |
8 |
113,715,211 |
113,737,063 |
RGD:6480464 |
CTD |
| G |
Slc25a22 |
solute carrier family 25 (mitochondrial carrier, glutamate), member 22 |
|
decreases expression |
ISO |
1 |
201,617,689 |
201,625,537 |
RGD:6480464 |
CTD |
| G |
Slc25a30 |
solute carrier family 25, member 30 |
|
decreases expression |
ISO |
15 |
56,656,204 |
56,695,237 |
RGD:6480464 |
CTD |
| G |
Slc25a30 |
solute carrier family 25, member 30 |
|
affects expression |
EXP |
15 |
56,656,204 |
56,695,237 |
RGD:6480464 |
CTD |
| G |
Slc25a37 |
solute carrier family 25 (mitochondrial iron transporter), member 37 |
|
increases expression |
ISO |
15 |
49,806,324 |
49,846,988 |
RGD:6480464 |
CTD |
| G |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
|
multiple interactions |
ISO |
16 |
49,353,476 |
49,357,271 |
RGD:6480464 |
CTD |
| G |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
|
decreases expression |
ISO |
16 |
49,353,476 |
49,357,271 |
RGD:6480464 |
CTD |
| G |
Slc25a47 |
solute carrier family 25, member 47 |
|
multiple interactions |
ISO |
6 |
133,192,144 |
133,197,778 |
RGD:6480464 |
CTD |
| G |
Slc25a47 |
solute carrier family 25, member 47 |
|
decreases expression |
ISO |
6 |
133,192,144 |
133,197,778 |
RGD:6480464 |
CTD |
| G |
Slc26a4 |
solute carrier family 26, member 4 |
|
multiple interactions |
ISO |
6 |
49,389,212 |
49,427,000 |
RGD:6480464 |
CTD |
| G |
Slc26a4 |
solute carrier family 26, member 4 |
|
increases expression |
ISO |
6 |
49,389,212 |
49,427,000 |
RGD:6480464 |
CTD |
| G |
Slc28a2 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 |
|
decreases expression |
EXP |
3 |
109,350,531 |
109,372,027 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
multiple interactions |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
decreases activity |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
decreases expression |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
increases expression |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
decreases expression |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc30a10 |
solute carrier family 30, member 10 |
|
multiple interactions |
ISO |
13 |
101,474,867 |
101,492,180 |
RGD:6480464 |
CTD |
| G |
Slc30a10 |
solute carrier family 30, member 10 |
|
decreases expression |
ISO |
13 |
101,474,867 |
101,492,180 |
RGD:6480464 |
CTD |
| G |
Slc35a3 |
solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 |
|
increases expression |
ISO |
2 |
212,902,953 |
212,939,222 |
RGD:6480464 |
CTD |
| G |
Slc35b1 |
solute carrier family 35, member B1 |
|
increases expression |
EXP |
10 |
84,069,903 |
84,076,976 |
RGD:6480464 |
CTD |
| G |
Slc35g1 |
solute carrier family 35, member G1 |
|
increases expression |
ISO |
1 |
242,713,535 |
242,719,969 |
RGD:6480464 |
CTD |
| G |
Slc37a1 |
solute carrier family 37 (glycerol-3-phosphate transporter), member 1 |
|
multiple interactions |
ISO |
20 |
9,689,661 |
9,745,102 |
RGD:6480464 |
CTD |
| G |
Slc37a1 |
solute carrier family 37 (glycerol-3-phosphate transporter), member 1 |
|
increases expression |
ISO |
20 |
9,689,661 |
9,745,102 |
RGD:6480464 |
CTD |
| G |
Slc37a4 |
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
|
increases expression |
ISO |
8 |
47,363,896 |
47,369,981 |
RGD:6480464 |
CTD |
| G |
Slc37a4 |
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
|
decreases expression |
EXP |
8 |
47,363,896 |
47,369,981 |
RGD:6480464 |
CTD |
| G |
Slc38a2 |
solute carrier family 38, member 2 |
|
decreases expression |
ISO |
7 |
135,365,172 |
135,377,341 |
RGD:6480464 |
CTD |
| G |
Slc38a9 |
solute carrier family 38, member 9 |
|
decreases methylation |
ISO |
2 |
44,044,770 |
44,110,884 |
RGD:6480464 |
CTD |
| G |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
|
increases expression |
ISO |
7 |
114,661,925 |
114,666,098 |
RGD:6480464 |
CTD |
| G |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
|
multiple interactions |
ISO |
7 |
114,661,925 |
114,666,098 |
RGD:6480464 |
CTD |
| G |
Slc3a1 |
solute carrier family 3, member 1 |
|
decreases expression |
ISO |
6 |
8,385,186 |
8,419,465 |
RGD:6480464 |
CTD |
| G |
Slc3a1 |
solute carrier family 3, member 1 |
|
multiple interactions |
ISO |
6 |
8,385,186 |
8,419,465 |
RGD:6480464 |
CTD |
| G |
Slc3a2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression |
EXP |
1 |
211,375,889 |
211,390,313 |
RGD:6480464 |
CTD |
| G |
Slc41a2 |
solute carrier family 41, member 2 |
|
decreases expression |
ISO |
7 |
22,583,232 |
22,669,674 |
RGD:6480464 |
CTD |
| G |
Slc45a3 |
solute carrier family 45, member 3 |
|
decreases expression |
ISO |
13 |
44,840,555 |
44,861,173 |
RGD:6480464 |
CTD |
| G |
Slc48a1 |
solute carrier family 48 (heme transporter), member 1 |
|
multiple interactions |
ISO |
7 |
136,492,421 |
136,500,222 |
RGD:6480464 |
CTD |
| G |
Slc48a1 |
solute carrier family 48 (heme transporter), member 1 |
|
increases expression |
ISO |
7 |
136,492,421 |
136,500,222 |
RGD:6480464 |
CTD |
| G |
Slc4a4 |
solute carrier family 4, sodium bicarbonate cotransporter, member 4 |
|
decreases expression |
EXP |
14 |
20,381,545 |
20,739,216 |
RGD:6480464 |
CTD |
| G |
Slc4a4 |
solute carrier family 4, sodium bicarbonate cotransporter, member 4 |
|
affects expression |
ISO |
14 |
20,381,545 |
20,739,216 |
RGD:6480464 |
CTD |
| G |
Slc50a1 |
solute carrier family 50 (sugar transporter), member 1 |
|
increases expression |
ISO |
2 |
181,440,905 |
181,443,285 |
RGD:6480464 |
CTD |
| G |
Slc5a6 |
solute carrier family 5 (sodium-dependent vitamin transporter), member 6 |
|
increases expression |
ISO |
6 |
25,301,630 |
25,312,901 |
RGD:6480464 |
CTD |
| G |
Slc6a13 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 13 |
|
decreases expression |
EXP |
4 |
157,736,264 |
157,771,945 |
RGD:6480464 |
CTD |
| G |
Slc6a9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
|
multiple interactions |
ISO |
5 |
138,300,869 |
138,334,893 |
RGD:6480464 |
CTD |
| G |
Slc6a9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
|
increases expression |
ISO |
5 |
138,300,869 |
138,334,893 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
multiple interactions |
ISO |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
increases expression |
ISO |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Slc7a2 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
|
multiple interactions |
ISO |
16 |
54,752,119 |
54,805,406 |
RGD:6480464 |
CTD |
| G |
Slc7a2 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
|
decreases expression |
ISO |
16 |
54,752,119 |
54,805,406 |
RGD:6480464 |
CTD |
| G |
Slc7a2 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
|
increases expression |
ISO |
16 |
54,752,119 |
54,805,406 |
RGD:6480464 |
CTD |
| G |
Slc7a5 |
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
|
multiple interactions |
ISO |
19 |
52,120,728 |
52,149,332 |
RGD:6480464 |
CTD |
| G |
Slc7a5 |
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
|
increases expression |
ISO |
19 |
52,120,728 |
52,149,332 |
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
decreases expression |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
|
decreases expression |
ISO |
8 |
108,012,829 |
108,098,561 |
RGD:6480464 |
CTD |
| G |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
|
multiple interactions |
ISO |
8 |
108,012,829 |
108,098,561 |
RGD:6480464 |
CTD |
| G |
Slco2b1 |
solute carrier organic anion transporter family, member 2b1 |
|
decreases expression |
ISO |
1 |
156,992,492 |
157,028,887 |
RGD:6480464 |
CTD |
| G |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
|
increases expression |
EXP |
8 |
20,720,915 |
20,812,157 |
RGD:6480464 |
CTD |
| G |
Smc2 |
structural maintenance of chromosomes 2 |
|
affects expression |
ISO |
5 |
69,561,142 |
69,607,373 |
RGD:6480464 |
CTD |
| G |
Smc4 |
structural maintenance of chromosomes 4 |
|
multiple interactions |
ISO |
2 |
158,987,318 |
159,015,705 |
RGD:6480464 |
CTD |
| G |
Smc4 |
structural maintenance of chromosomes 4 |
|
increases expression |
ISO |
2 |
158,987,318 |
159,015,705 |
RGD:6480464 |
CTD |
| G |
Smo |
smoothened, frizzled family receptor |
|
multiple interactions |
ISO |
4 |
56,623,494 |
56,645,571 |
RGD:6480464 |
CTD |
| G |
Smo |
smoothened, frizzled family receptor |
|
decreases expression |
ISO |
4 |
56,623,494 |
56,645,571 |
RGD:6480464 |
CTD |
| G |
Smpd2 |
sphingomyelin phosphodiesterase 2, neutral membrane |
|
multiple interactions |
ISO |
20 |
45,448,774 |
45,451,887 |
RGD:6480464 |
CTD |
| G |
Smpd2 |
sphingomyelin phosphodiesterase 2, neutral membrane |
|
increases expression |
ISO |
20 |
45,448,774 |
45,451,887 |
RGD:6480464 |
CTD |
| G |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral membrane |
|
increases expression |
ISO |
19 |
36,112,166 |
36,195,564 |
RGD:6480464 |
CTD |
| G |
Smyd5 |
SMYD family member 5 |
|
decreases expression |
EXP |
4 |
119,686,587 |
119,701,588 |
RGD:6480464 |
CTD |
| G |
Snap25 |
synaptosomal-associated protein 25 |
|
decreases expression |
EXP |
3 |
124,806,637 |
124,894,653 |
RGD:6480464 |
CTD |
| G |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
|
increases expression |
EXP |
4 |
55,350,745 |
55,761,185 |
RGD:6480464 |
CTD |
| G |
Snf1lk2 |
SNF1-like kinase 2 |
|
increases expression |
EXP |
8 |
54,240,307 |
54,337,976 |
RGD:6480464 |
CTD |
| G |
Snhg11 |
small nucleolar RNA host gene 11 (non-protein coding) |
|
multiple interactions |
ISO |
3 |
149,094,213 |
149,102,475 |
RGD:6480464 |
CTD |
| G |
Snhg11 |
small nucleolar RNA host gene 11 (non-protein coding) |
|
increases expression |
ISO |
3 |
149,094,213 |
149,102,475 |
RGD:6480464 |
CTD |
| G |
Sntg2 |
syntrophin, gamma 2 |
|
multiple interactions |
ISO |
6 |
48,059,246 |
48,263,991 |
RGD:6480464 |
CTD |
| G |
Sntg2 |
syntrophin, gamma 2 |
|
decreases expression |
ISO |
6 |
48,059,246 |
48,263,991 |
RGD:6480464 |
CTD |
| G |
Snx10 |
sorting nexin 10 |
|
multiple interactions |
ISO |
4 |
79,789,556 |
79,853,215 |
RGD:6480464 |
CTD |
| G |
Snx10 |
sorting nexin 10 |
|
increases expression |
ISO |
4 |
79,789,556 |
79,853,215 |
RGD:6480464 |
CTD |
| G |
Snx16 |
sorting nexin 16 |
|
increases expression |
ISO |
2 |
93,274,839 |
93,296,194 |
RGD:6480464 |
CTD |
| G |
Snx16 |
sorting nexin 16 |
|
multiple interactions |
ISO |
2 |
93,274,839 |
93,296,194 |
RGD:6480464 |
CTD |
| G |
Snx33 |
sorting nexin 33 |
|
decreases expression |
ISO |
8 |
60,663,024 |
60,673,400 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
multiple interactions |
ISO |
14 |
63,381,447 |
63,387,180 |
RGD:6480464 |
CTD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
decreases expression |
ISO |
14 |
63,381,447 |
63,387,180 |
RGD:6480464 |
CTD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
decreases expression |
EXP |
14 |
63,381,447 |
63,387,180 |
RGD:6480464 |
CTD |
| G |
Solh |
small optic lobes homolog (Drosophila) |
|
affects expression |
ISO |
10 |
15,218,517 |
15,245,117 |
RGD:6480464 |
CTD |
| G |
Sorbs2 |
sorbin and SH3 domain containing 2 |
|
decreases expression |
EXP |
16 |
49,722,539 |
49,917,550 |
RGD:6480464 |
CTD |
| G |
Sowahb |
sosondowah ankyrin repeat domain family member B |
|
multiple interactions |
ISO |
14 |
16,587,783 |
16,590,086 |
RGD:6480464 |
CTD |
| G |
Sowahb |
sosondowah ankyrin repeat domain family member B |
|
increases expression |
ISO |
14 |
16,587,783 |
16,590,086 |
RGD:6480464 |
CTD |
| G |
Sowahb |
sosondowah ankyrin repeat domain family member B |
|
decreases expression |
ISO |
14 |
16,587,783 |
16,590,086 |
RGD:6480464 |
CTD |
| G |
Sprr1a |
small proline-rich protein 1A |
|
increases expression |
ISO |
2 |
185,463,951 |
185,465,849 |
RGD:6480464 |
CTD |
| G |
Sptlc2 |
serine palmitoyltransferase, long chain base subunit 2 |
|
multiple interactions |
ISO |
6 |
111,546,037 |
111,622,959 |
RGD:6480464 |
CTD |
| G |
Sptlc2 |
serine palmitoyltransferase, long chain base subunit 2 |
|
increases expression |
ISO |
6 |
111,546,037 |
111,622,959 |
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
increases expression |
EXP |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Sqstm1 |
sequestosome 1 |
|
multiple interactions |
ISO |
10 |
35,751,300 |
35,762,630 |
RGD:6480464 |
CTD |
| G |
Sqstm1 |
sequestosome 1 |
|
increases expression |
ISO |
10 |
35,751,300 |
35,762,630 |
RGD:6480464 |
CTD |
| G |
Srcrb4d |
scavenger receptor cysteine rich domain containing, group B (4 domains) |
|
multiple interactions |
ISO |
12 |
21,823,241 |
21,833,274 |
RGD:6480464 |
CTD |
| G |
Srcrb4d |
scavenger receptor cysteine rich domain containing, group B (4 domains) |
|
increases expression |
ISO |
12 |
21,823,241 |
21,833,274 |
RGD:6480464 |
CTD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
increases expression |
ISO |
17 |
3,845,190 |
3,879,165 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
decreases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
decreases expression |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srgn |
serglycin |
|
decreases expression |
ISO |
20 |
29,746,729 |
29,761,072 |
RGD:6480464 |
CTD |
| G |
Srgn |
serglycin |
|
multiple interactions |
ISO |
20 |
29,746,729 |
29,761,072 |
RGD:6480464 |
CTD |
| G |
Srms |
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites |
|
affects methylation |
ISO |
3 |
170,347,942 |
170,354,346 |
RGD:6480464 |
CTD |
| G |
Srms |
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites |
|
increases methylation |
ISO |
3 |
170,347,942 |
170,354,346 |
RGD:6480464 |
CTD |
| G |
Srsf5 |
serine/arginine-rich splicing factor 5 |
|
increases expression |
ISO |
6 |
104,728,286 |
104,732,982 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 |
|
increases expression |
ISO |
3 |
142,457,352 |
142,462,725 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 |
|
multiple interactions |
ISO |
3 |
142,457,352 |
142,462,725 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 |
|
affects expression |
ISO |
3 |
142,457,352 |
142,462,725 |
RGD:6480464 |
CTD |
| G |
Ssr3 |
signal sequence receptor, gamma |
|
increases expression |
ISO |
2 |
155,147,350 |
155,156,029 |
RGD:6480464 |
CTD |
| G |
Ssr3 |
signal sequence receptor, gamma |
|
increases expression |
EXP |
2 |
155,147,350 |
155,156,029 |
RGD:6480464 |
CTD |
| G |
St13 |
suppression of tumorigenicity 13 |
|
increases expression |
EXP |
7 |
119,694,123 |
119,728,936 |
RGD:6480464 |
CTD |
| G |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
|
decreases expression |
ISO |
8 |
34,845,949 |
34,894,795 |
RGD:6480464 |
CTD |
| G |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
|
increases expression |
ISO |
8 |
34,845,949 |
34,894,795 |
RGD:6480464 |
CTD |
| G |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
|
multiple interactions |
ISO |
8 |
34,845,949 |
34,894,795 |
RGD:6480464 |
CTD |
| G |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
|
multiple interactions |
ISO |
4 |
105,373,385 |
105,432,192 |
RGD:6480464 |
CTD |
| G |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
|
decreases expression |
ISO |
4 |
105,373,385 |
105,432,192 |
RGD:6480464 |
CTD |
| G |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
|
increases expression |
ISO |
4 |
105,373,385 |
105,432,192 |
RGD:6480464 |
CTD |
| G |
St5 |
suppression of tumorigenicity 5 |
|
decreases expression |
ISO |
1 |
167,119,711 |
167,284,482 |
RGD:6480464 |
CTD |
| G |
Stab1 |
stabilin 1 |
|
multiple interactions |
ISO |
16 |
6,567,583 |
6,597,972 |
RGD:6480464 |
CTD |
| G |
Stab1 |
stabilin 1 |
|
decreases expression |
ISO |
16 |
6,567,583 |
6,597,972 |
RGD:6480464 |
CTD |
| G |
Stab2 |
stabilin 2 |
|
multiple interactions |
ISO |
7 |
23,470,117 |
23,497,983 |
RGD:6480464 |
CTD |
| G |
Stab2 |
stabilin 2 |
|
decreases expression |
ISO |
7 |
23,470,117 |
23,497,983 |
RGD:6480464 |
CTD |
| G |
Stambp |
Stam binding protein |
|
increases expression |
ISO |
4 |
117,766,905 |
117,791,399 |
RGD:6480464 |
CTD |
| G |
Stap1 |
signal transducing adaptor family member 1 |
|
multiple interactions |
ISO |
14 |
23,734,558 |
23,764,077 |
RGD:6480464 |
CTD |
| G |
Stap1 |
signal transducing adaptor family member 1 |
|
decreases expression |
ISO |
14 |
23,734,558 |
23,764,077 |
RGD:6480464 |
CTD |
| G |
Stard3nl |
STARD3 N-terminal like |
|
increases expression |
ISO |
17 |
53,402,078 |
53,436,085 |
RGD:6480464 |
CTD |
| G |
Stard5 |
StAR-related lipid transfer (START) domain containing 5 |
|
increases expression |
ISO |
1 |
139,896,268 |
139,906,134 |
RGD:6480464 |
CTD |
| G |
Stbd1 |
starch binding domain 1 |
|
increases expression |
ISO |
14 |
17,031,752 |
17,035,157 |
RGD:6480464 |
CTD |
| G |
Stbd1 |
starch binding domain 1 |
|
multiple interactions |
ISO |
14 |
17,031,752 |
17,035,157 |
RGD:6480464 |
CTD |
| G |
Steap4 |
STEAP family member 4 |
|
multiple interactions |
ISO |
4 |
22,688,597 |
22,711,432 |
RGD:6480464 |
CTD |
| G |
Steap4 |
STEAP family member 4 |
|
decreases expression |
ISO |
4 |
22,688,597 |
22,711,432 |
RGD:6480464 |
CTD |
| G |
Stim2 |
stromal interaction molecule 2 |
|
increases expression |
ISO |
14 |
61,630,737 |
61,759,846 |
RGD:6480464 |
CTD |
| G |
Stip1 |
stress-induced phosphoprotein 1 |
|
affects expression |
EXP |
1 |
209,693,427 |
209,712,779 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
increases expression |
EXP |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
increases expression |
ISO |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Strbp |
spermatid perinuclear RNA binding protein |
|
multiple interactions |
ISO |
3 |
17,338,337 |
17,411,975 |
RGD:6480464 |
CTD |
| G |
Strbp |
spermatid perinuclear RNA binding protein |
|
increases expression |
ISO |
3 |
17,338,337 |
17,411,975 |
RGD:6480464 |
CTD |
| G |
Stxbp2 |
syntaxin binding protein 2 |
|
decreases expression |
EXP |
12 |
2,511,793 |
2,522,818 |
RGD:6480464 |
CTD |
| G |
Sucnr1 |
succinate receptor 1 |
|
multiple interactions |
ISO |
2 |
149,416,068 |
149,417,021 |
RGD:6480464 |
CTD |
| G |
Sucnr1 |
succinate receptor 1 |
|
decreases expression |
ISO |
2 |
149,416,068 |
149,417,021 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
decreases expression |
EXP |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
increases expression |
EXP |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1b1 |
sulfotransferase family, cytosolic, 1B, member 1 |
|
increases expression |
EXP |
14 |
22,019,193 |
22,031,914 |
RGD:6480464 |
CTD |
| G |
Sult1c2 |
sulfotransferase family, cytosolic, 1C, member 2 |
|
increases expression |
ISO |
9 |
972,522 |
998,125 |
RGD:6480464 |
CTD |
| G |
Sult1c2 |
sulfotransferase family, cytosolic, 1C, member 2 |
|
multiple interactions |
ISO |
9 |
972,522 |
998,125 |
RGD:6480464 |
CTD |
| G |
Sult1d1 |
sulfotransferase family 1D, member 1 |
|
multiple interactions |
ISO |
14 |
21,983,705 |
22,002,744 |
RGD:6480464 |
CTD |
| G |
Sult1d1 |
sulfotransferase family 1D, member 1 |
|
increases expression |
ISO |
14 |
21,983,705 |
22,002,744 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
multiple interactions |
ISO |
14 |
21,948,475 |
21,965,541 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
increases expression |
ISO |
14 |
21,948,475 |
21,965,541 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
increases expression |
EXP |
14 |
21,948,475 |
21,965,541 |
RGD:6480464 |
CTD |
| G |
Sult2a1 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
|
increases expression |
ISO |
1 |
75,632,632 |
75,708,022 |
RGD:6480464 |
CTD |
| G |
Sult2a1 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
|
increases expression |
ISO |
1 |
75,632,632 |
75,708,022 |
RGD:6480464 |
CTD |
| G |
Sult2a1 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
|
decreases expression |
EXP |
1 |
75,632,632 |
75,708,022 |
RGD:6480464 |
CTD |
| G |
Sult2a6 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 6 |
|
decreases expression |
EXP |
1 |
74,553,799 |
74,605,247 |
RGD:6480464 |
CTD |
| G |
Sult5a1 |
sulfotransferase family 5A, member 1 |
|
affects expression |
ISO |
19 |
53,472,683 |
53,498,840 |
RGD:6480464 |
CTD |
| G |
Sult5a1 |
sulfotransferase family 5A, member 1 |
|
increases expression |
ISO |
19 |
53,472,683 |
53,498,840 |
RGD:6480464 |
CTD |
| G |
Susd4 |
sushi domain containing 4 |
|
multiple interactions |
ISO |
13 |
98,831,087 |
98,950,911 |
RGD:6480464 |
CTD |
| G |
Susd4 |
sushi domain containing 4 |
|
decreases expression |
ISO |
13 |
98,831,087 |
98,950,911 |
RGD:6480464 |
CTD |
| G |
Syde2 |
synapse defective 1, Rho GTPase, homolog 2 (C. elegans) |
|
multiple interactions |
ISO |
2 |
244,166,412 |
244,199,033 |
RGD:6480464 |
CTD |
| G |
Syde2 |
synapse defective 1, Rho GTPase, homolog 2 (C. elegans) |
|
decreases expression |
ISO |
2 |
244,166,412 |
244,199,033 |
RGD:6480464 |
CTD |
| G |
Syn1 |
synapsin I |
|
affects expression |
ISO |
X |
12,512,241 |
12,556,160 |
RGD:6480464 |
CTD |
| G |
Synpo |
synaptopodin |
|
multiple interactions |
ISO |
18 |
56,552,991 |
56,573,981 |
RGD:6480464 |
CTD |
| G |
Synpo |
synaptopodin |
|
increases expression |
ISO |
18 |
56,552,991 |
56,573,981 |
RGD:6480464 |
CTD |
| G |
Syt12 |
synaptotagmin XII |
|
multiple interactions |
ISO |
1 |
207,021,672 |
207,073,026 |
RGD:6480464 |
CTD |
| G |
Syt12 |
synaptotagmin XII |
|
increases expression |
ISO |
1 |
207,021,672 |
207,073,026 |
RGD:6480464 |
CTD |
| G |
Syt12 |
synaptotagmin XII |
|
decreases expression |
EXP |
1 |
207,021,672 |
207,073,026 |
RGD:6480464 |
CTD |
| G |
Tab2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
|
decreases expression |
ISO |
1 |
2,568,536 |
2,617,742 |
RGD:6480464 |
CTD |
| G |
Tacc1 |
transforming, acidic coiled-coil containing protein 1 |
|
multiple interactions |
ISO |
16 |
71,241,785 |
71,304,959 |
RGD:6480464 |
CTD |
| G |
Tacc1 |
transforming, acidic coiled-coil containing protein 1 |
|
decreases expression |
ISO |
16 |
71,241,785 |
71,304,959 |
RGD:6480464 |
CTD |
| G |
Tacc3 |
transforming, acidic coiled-coil containing protein 3 |
|
multiple interactions |
ISO |
14 |
82,746,460 |
82,760,864 |
RGD:6480464 |
CTD |
| G |
Tacc3 |
transforming, acidic coiled-coil containing protein 3 |
|
affects expression |
ISO |
14 |
82,746,460 |
82,760,864 |
RGD:6480464 |
CTD |
| G |
Tacc3 |
transforming, acidic coiled-coil containing protein 3 |
|
increases expression |
ISO |
14 |
82,746,460 |
82,760,864 |
RGD:6480464 |
CTD |
| G |
Tanc1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
|
increases expression |
ISO |
3 |
41,364,205 |
41,563,655 |
RGD:6480464 |
CTD |
| G |
Taok3 |
TAO kinase 3 |
|
decreases expression |
ISO |
12 |
40,502,499 |
40,583,816 |
RGD:6480464 |
CTD |
| G |
Tars |
threonyl-tRNA synthetase |
|
multiple interactions |
ISO |
2 |
60,765,899 |
60,784,665 |
RGD:6480464 |
CTD |
| G |
Tars |
threonyl-tRNA synthetase |
|
decreases expression |
ISO |
2 |
60,765,899 |
60,784,665 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
multiple interactions |
ISO |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
decreases expression |
ISO |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
decreases expression |
EXP |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tbc1d10a |
TBC1 domain family, member 10a |
|
affects expression |
ISO |
14 |
84,810,214 |
84,837,928 |
RGD:6480464 |
CTD |
| G |
Tbce |
tubulin folding cofactor E |
|
increases expression |
EXP |
17 |
59,485,451 |
59,533,041 |
RGD:6480464 |
CTD |
| G |
Tbcel |
tubulin folding cofactor E-like |
|
multiple interactions |
ISO |
8 |
45,403,536 |
45,459,207 |
RGD:6480464 |
CTD |
| G |
Tbcel |
tubulin folding cofactor E-like |
|
increases expression |
ISO |
8 |
45,403,536 |
45,459,207 |
RGD:6480464 |
CTD |
| G |
Tbx3 |
T-box 3 |
|
multiple interactions |
ISO |
12 |
38,155,494 |
38,166,670 |
RGD:6480464 |
CTD |
| G |
Tbx3 |
T-box 3 |
|
decreases expression |
ISO |
12 |
38,155,494 |
38,166,670 |
RGD:6480464 |
CTD |
| G |
Tbxas1 |
thromboxane A synthase 1, platelet |
|
multiple interactions |
EXP |
4 |
66,502,253 |
66,677,538 |
RGD:6480464 |
CTD |
| G |
Tceal8 |
transcription elongation factor A (SII)-like 8 |
|
multiple interactions |
ISO |
X |
123,481,666 |
123,482,635 |
RGD:6480464 |
CTD |
| G |
Tceal8 |
transcription elongation factor A (SII)-like 8 |
|
affects expression |
ISO |
X |
123,481,666 |
123,482,635 |
RGD:6480464 |
CTD |
| G |
Tceal8 |
transcription elongation factor A (SII)-like 8 |
|
increases expression |
ISO |
X |
123,481,666 |
123,482,635 |
RGD:6480464 |
CTD |
| G |
Tcf21 |
transcription factor 21 |
|
decreases expression |
ISO |
1 |
23,211,054 |
23,213,913 |
RGD:6480464 |
CTD |
| G |
Tcf21 |
transcription factor 21 |
|
multiple interactions |
ISO |
1 |
23,211,054 |
23,213,913 |
RGD:6480464 |
CTD |
| G |
Tcf4 |
transcription factor 4 |
|
affects methylation |
ISO |
18 |
66,135,863 |
66,359,984 |
RGD:6480464 |
CTD |
| G |
Tcf7 |
transcription factor 7 (T-cell specific, HMG-box) |
|
multiple interactions |
ISO |
10 |
37,686,862 |
37,716,831 |
RGD:6480464 |
CTD |
| G |
Tcf7 |
transcription factor 7 (T-cell specific, HMG-box) |
|
increases expression |
ISO |
10 |
37,686,862 |
37,716,831 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
affects expression |
EXP |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tff3 |
trefoil factor 3, intestinal |
|
decreases expression |
ISO |
20 |
9,469,888 |
9,474,604 |
RGD:6480464 |
CTD |
| G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
|
affects expression |
ISO |
4 |
28,807,080 |
28,811,502 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases activity |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
multiple interactions |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfbi |
transforming growth factor, beta induced |
|
multiple interactions |
ISO |
17 |
13,904,882 |
13,935,110 |
RGD:6480464 |
CTD |
| G |
Tgfbi |
transforming growth factor, beta induced |
|
decreases expression |
ISO |
17 |
13,904,882 |
13,935,110 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
multiple interactions |
ISO |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
increases expression |
ISO |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
multiple interactions |
EXP |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
multiple interactions |
EXP |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tgfbr3 |
transforming growth factor, beta receptor III |
|
multiple interactions |
ISO |
14 |
3,051,039 |
3,240,286 |
RGD:6480464 |
CTD |
| G |
Tgfbr3 |
transforming growth factor, beta receptor III |
|
decreases expression |
ISO |
14 |
3,051,039 |
3,240,286 |
RGD:6480464 |
CTD |
| G |
Tgfbr3 |
transforming growth factor, beta receptor III |
|
multiple interactions |
EXP |
14 |
3,051,039 |
3,240,286 |
RGD:6480464 |
CTD |
| G |
Tgfbr3 |
transforming growth factor, beta receptor III |
|
multiple interactions |
EXP |
14 |
3,051,039 |
3,240,286 |
RGD:6480464 |
CTD |
| G |
Tgif1 |
TGFB-induced factor homeobox 1 |
|
increases expression |
ISO |
9 |
110,043,164 |
110,052,783 |
RGD:6480464 |
CTD |
| G |
Tgm1 |
transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) |
|
multiple interactions |
ISO |
15 |
33,846,367 |
33,859,615 |
RGD:6480464 |
CTD |
| G |
Tgm1 |
transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) |
|
decreases expression |
ISO |
15 |
33,846,367 |
33,859,615 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
multiple interactions |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases expression |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
affects expression |
ISO |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
increases expression |
ISO |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
decreases expression |
EXP |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Thumpd1 |
THUMP domain containing 1 |
|
multiple interactions |
ISO |
1 |
177,997,217 |
178,003,994 |
RGD:6480464 |
CTD |
| G |
Thumpd1 |
THUMP domain containing 1 |
|
increases expression |
ISO |
1 |
177,997,217 |
178,003,994 |
RGD:6480464 |
CTD |
| G |
Tiam2 |
T-cell lymphoma invasion and metastasis 2 |
|
increases expression |
ISO |
1 |
38,479,385 |
38,514,359 |
RGD:6480464 |
CTD |
| G |
Tie1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
|
increases expression |
ISO |
5 |
138,945,238 |
138,964,631 |
RGD:6480464 |
CTD |
| G |
Tifa |
TRAF-interacting protein with forkhead-associated domain |
|
increases expression |
ISO |
2 |
225,067,695 |
225,076,898 |
RGD:6480464 |
CTD |
| G |
Timeless |
timeless circadian clock |
|
affects expression |
ISO |
7 |
1,516,568 |
1,540,512 |
RGD:6480464 |
CTD |
| G |
Timm17a |
translocase of inner mitochondrial membrane 17 homolog A (yeast) |
|
increases expression |
EXP |
13 |
48,297,516 |
48,309,303 |
RGD:6480464 |
CTD |
| G |
Timm23 |
translocase of inner mitochondrial membrane 23 homolog (yeast) |
|
increases expression |
EXP |
16 |
7,663,204 |
7,689,233 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Tinag |
tubulointerstitial nephritis antigen |
|
multiple interactions |
ISO |
8 |
81,947,234 |
82,032,994 |
RGD:6480464 |
CTD |
| G |
Tinag |
tubulointerstitial nephritis antigen |
|
increases expression |
ISO |
8 |
81,947,234 |
82,032,994 |
RGD:6480464 |
CTD |
| G |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
|
multiple interactions |
ISO |
5 |
149,198,274 |
149,207,653 |
RGD:6480464 |
CTD |
| G |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
|
decreases expression |
ISO |
5 |
149,198,274 |
149,207,653 |
RGD:6480464 |
CTD |
| G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
|
increases expression |
ISO |
2 |
155,312,341 |
155,339,357 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
increases expression |
EXP |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tjp3 |
tight junction protein 3 |
|
decreases expression |
ISO |
7 |
9,917,359 |
9,930,081 |
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tkt |
transketolase |
|
increases expression |
EXP |
16 |
5,908,759 |
5,933,695 |
RGD:6480464 |
CTD |
| G |
Tlcd2 |
TLC domain containing 2 |
|
decreases expression |
ISO |
10 |
62,786,854 |
62,791,350 |
RGD:6480464 |
CTD |
| G |
Tlcd2 |
TLC domain containing 2 |
|
multiple interactions |
ISO |
10 |
62,786,854 |
62,791,350 |
RGD:6480464 |
CTD |
| G |
Tle1 |
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) |
|
decreases expression |
ISO |
5 |
89,682,837 |
89,765,682 |
RGD:6480464 |
CTD |
| G |
Tlr12 |
toll-like receptor 12 |
|
multiple interactions |
ISO |
5 |
147,842,062 |
147,845,067 |
RGD:6480464 |
CTD |
| G |
Tlr12 |
toll-like receptor 12 |
|
increases expression |
ISO |
5 |
147,842,062 |
147,845,067 |
RGD:6480464 |
CTD |
| G |
Tm6sf2 |
transmembrane 6 superfamily member 2 |
|
multiple interactions |
ISO |
16 |
19,827,481 |
19,834,693 |
RGD:6480464 |
CTD |
| G |
Tm6sf2 |
transmembrane 6 superfamily member 2 |
|
increases expression |
ISO |
16 |
19,827,481 |
19,834,693 |
RGD:6480464 |
CTD |
| G |
Tmc5 |
transmembrane channel-like 5 |
|
increases expression |
ISO |
1 |
176,854,487 |
176,865,156 |
RGD:6480464 |
CTD |
| G |
Tmc5 |
transmembrane channel-like 5 |
|
multiple interactions |
ISO |
1 |
176,854,487 |
176,865,156 |
RGD:6480464 |
CTD |
| G |
Tmed3 |
transmembrane emp24 protein transport domain containing 3 |
|
increases expression |
ISO |
8 |
94,590,177 |
94,598,090 |
RGD:6480464 |
CTD |
| G |
Tmem106b |
transmembrane protein 106B |
|
increases expression |
ISO |
4 |
38,398,245 |
38,415,059 |
RGD:6480464 |
CTD |
| G |
Tmem132d |
transmembrane protein 132D |
|
affects methylation |
ISO |
12 |
29,495,711 |
29,964,532 |
RGD:6480464 |
CTD |
| G |
Tmem14a |
transmembrane protein 14A |
|
increases expression |
ISO |
9 |
19,986,826 |
19,999,299 |
RGD:6480464 |
CTD |
| G |
Tmem184b |
transmembrane protein 184B |
|
multiple interactions |
ISO |
7 |
117,341,517 |
117,385,225 |
RGD:6480464 |
CTD |
| G |
Tmem184b |
transmembrane protein 184B |
|
increases expression |
ISO |
7 |
117,341,517 |
117,385,225 |
RGD:6480464 |
CTD |
| G |
Tmem184c |
transmembrane protein 184C |
|
multiple interactions |
ISO |
19 |
32,158,361 |
32,174,009 |
RGD:6480464 |
CTD |
| G |
Tmem184c |
transmembrane protein 184C |
|
decreases expression |
ISO |
19 |
32,158,361 |
32,174,009 |
RGD:6480464 |
CTD |
| G |
Tmem204 |
transmembrane protein 204 |
|
decreases expression |
ISO |
10 |
14,304,565 |
14,329,967 |
RGD:6480464 |
CTD |
| G |
Tmem204 |
transmembrane protein 204 |
|
multiple interactions |
ISO |
10 |
14,304,565 |
14,329,967 |
RGD:6480464 |
CTD |
| G |
Tmem237 |
transmembrane protein 237 |
|
increases expression |
ISO |
9 |
57,663,702 |
57,696,158 |
RGD:6480464 |
CTD |
| G |
Tmem51 |
transmembrane protein 51 |
|
increases expression |
ISO |
5 |
160,938,672 |
160,988,578 |
RGD:6480464 |
CTD |
| G |
Tmem51 |
transmembrane protein 51 |
|
multiple interactions |
ISO |
5 |
160,938,672 |
160,988,578 |
RGD:6480464 |
CTD |
| G |
Tmem53 |
transmembrane protein 53 |
|
affects expression |
ISO |
5 |
137,559,894 |
137,575,740 |
RGD:6480464 |
CTD |
| G |
Tmem63a |
transmembrane protein 63a |
|
multiple interactions |
ISO |
13 |
96,671,527 |
96,704,177 |
RGD:6480464 |
CTD |
| G |
Tmem63a |
transmembrane protein 63a |
|
decreases expression |
ISO |
13 |
96,671,527 |
96,704,177 |
RGD:6480464 |
CTD |
| G |
Tmem69 |
transmembrane protein 69 |
|
increases expression |
EXP |
5 |
136,831,040 |
136,834,619 |
RGD:6480464 |
CTD |
| G |
Tmem97 |
transmembrane protein 97 |
|
increases expression |
ISO |
10 |
64,652,641 |
64,661,724 |
RGD:6480464 |
CTD |
| G |
Tmem97 |
transmembrane protein 97 |
|
multiple interactions |
ISO |
10 |
64,652,641 |
64,661,724 |
RGD:6480464 |
CTD |
| G |
Tmem98 |
transmembrane protein 98 |
|
decreases expression |
ISO |
10 |
69,028,338 |
69,039,247 |
RGD:6480464 |
CTD |
| G |
Tmem98 |
transmembrane protein 98 |
|
multiple interactions |
ISO |
10 |
69,028,338 |
69,039,247 |
RGD:6480464 |
CTD |
| G |
Tmpo |
thymopoietin |
|
decreases expression |
EXP |
7 |
28,086,576 |
28,111,800 |
RGD:6480464 |
CTD |
| G |
Tmprss2 |
transmembrane protease, serine 2 |
|
increases expression |
ISO |
11 |
37,577,051 |
37,617,258 |
RGD:6480464 |
CTD |
| G |
Tmprss2 |
transmembrane protease, serine 2 |
|
multiple interactions |
ISO |
11 |
37,577,051 |
37,617,258 |
RGD:6480464 |
CTD |
| G |
Tmsb10 |
thymosin, beta 10 |
|
decreases expression |
EXP |
4 |
106,286,030 |
106,287,089 |
RGD:6480464 |
CTD |
| G |
Tmtc2 |
transmembrane and tetratricopeptide repeat containing 2 |
|
increases expression |
ISO |
7 |
43,667,983 |
44,133,854 |
RGD:6480464 |
CTD |
| G |
Tmtc4 |
transmembrane and tetratricopeptide repeat containing 4 |
|
increases expression |
ISO |
15 |
108,061,644 |
108,118,409 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
|
decreases expression |
ISO |
6 |
136,196,746 |
136,210,410 |
RGD:6480464 |
CTD |
| G |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
|
increases expression |
ISO |
6 |
136,196,746 |
136,210,410 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
|
affects methylation |
ISO |
11 |
69,927,509 |
69,966,854 |
RGD:6480464 |
CTD |
| G |
Tob2 |
transducer of ERBB2, 2 |
|
decreases expression |
ISO |
7 |
120,200,815 |
120,209,535 |
RGD:6480464 |
CTD |
| G |
Tomm70a |
translocase of outer mitochondrial membrane 70 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
11 |
44,302,535 |
44,341,250 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
multiple interactions |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases expression |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases expression |
EXP |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tpd52 |
tumor protein D52 |
|
multiple interactions |
ISO |
2 |
94,850,203 |
94,880,802 |
RGD:6480464 |
CTD |
| G |
Tpd52 |
tumor protein D52 |
|
increases expression |
ISO |
2 |
94,850,203 |
94,880,802 |
RGD:6480464 |
CTD |
| G |
Tpd52 |
tumor protein D52 |
|
increases expression |
ISO |
2 |
94,850,203 |
94,880,802 |
RGD:6480464 |
CTD |
| G |
Tpd52l1 |
tumor protein D52-like 1 |
|
decreases expression |
ISO |
1 |
26,788,964 |
26,951,930 |
RGD:6480464 |
CTD |
| G |
Tpd52l1 |
tumor protein D52-like 1 |
|
multiple interactions |
ISO |
1 |
26,788,964 |
26,951,930 |
RGD:6480464 |
CTD |
| G |
Tpm2 |
tropomyosin 2, beta |
|
increases expression |
EXP |
5 |
59,994,101 |
60,003,261 |
RGD:6480464 |
CTD |
| G |
Tpmt |
thiopurine S-methyltransferase |
|
increases expression |
ISO |
17 |
23,697,900 |
23,714,173 |
RGD:6480464 |
CTD |
| G |
Tpr |
translocated promoter region, nuclear basket protein |
|
multiple interactions |
ISO |
13 |
64,688,585 |
64,753,555 |
RGD:6480464 |
CTD |
| G |
Tpr |
translocated promoter region, nuclear basket protein |
|
increases expression |
ISO |
13 |
64,688,585 |
64,753,555 |
RGD:6480464 |
CTD |
| G |
Tpst2 |
tyrosylprotein sulfotransferase 2 |
|
increases expression |
EXP |
19 |
14,283,684 |
14,297,517 |
RGD:6480464 |
CTD |
| G |
Trappc3 |
trafficking protein particle complex 3 |
|
increases expression |
ISO |
5 |
145,630,445 |
145,644,032 |
RGD:6480464 |
CTD |
| G |
Treh |
trehalase (brush-border membrane glycoprotein) |
|
affects expression |
ISO |
8 |
47,631,777 |
47,645,166 |
RGD:6480464 |
CTD |
| G |
Trib1 |
tribbles homolog 1 (Drosophila) |
|
decreases expression |
ISO |
7 |
96,442,239 |
96,448,785 |
RGD:6480464 |
CTD |
| G |
Trib2 |
tribbles homolog 2 (Drosophila) |
|
multiple interactions |
ISO |
6 |
39,474,243 |
39,496,718 |
RGD:6480464 |
CTD |
| G |
Trib2 |
tribbles homolog 2 (Drosophila) |
|
increases expression |
ISO |
6 |
39,474,243 |
39,496,718 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
increases expression |
ISO |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
increases expression |
EXP |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Trim2 |
tripartite motif-containing 2 |
|
multiple interactions |
ISO |
2 |
175,908,880 |
175,974,709 |
RGD:6480464 |
CTD |
| G |
Trim2 |
tripartite motif-containing 2 |
|
decreases expression |
ISO |
2 |
175,908,880 |
175,974,709 |
RGD:6480464 |
CTD |
| G |
Trim2 |
tripartite motif-containing 2 |
|
increases expression |
ISO |
2 |
175,908,880 |
175,974,709 |
RGD:6480464 |
CTD |
| G |
Trim32 |
tripartite motif-containing 32 |
|
increases expression |
ISO |
5 |
82,380,439 |
82,391,290 |
RGD:6480464 |
CTD |
| G |
Trim6 |
tripartite motif containing 6 |
|
affects expression |
ISO |
1 |
162,059,220 |
162,094,672 |
RGD:6480464 |
CTD |
| G |
Tspan13 |
tetraspanin 13 |
|
decreases expression |
ISO |
6 |
54,726,558 |
54,753,312 |
RGD:6480464 |
CTD |
| G |
Tspan3 |
tetraspanin 3 |
|
increases expression |
ISO |
8 |
59,739,961 |
59,764,317 |
RGD:6480464 |
CTD |
| G |
Tspo |
translocator protein |
|
multiple interactions |
ISO |
7 |
121,597,084 |
121,599,342 |
RGD:6480464 |
CTD |
| G |
Tspo |
translocator protein |
|
increases expression |
ISO |
7 |
121,597,084 |
121,599,342 |
RGD:6480464 |
CTD |
| G |
Tspyl4 |
TSPY-like 4 |
|
multiple interactions |
ISO |
20 |
38,639,281 |
38,641,277 |
RGD:6480464 |
CTD |
| G |
Tspyl4 |
TSPY-like 4 |
|
decreases expression |
ISO |
20 |
38,639,281 |
38,641,277 |
RGD:6480464 |
CTD |
| G |
Ttc30b |
tetratricopeptide repeat domain 30B |
|
increases expression |
ISO |
3 |
58,601,840 |
58,604,421 |
RGD:6480464 |
CTD |
| G |
Ttc38 |
tetratricopeptide repeat domain 38 |
|
multiple interactions |
ISO |
7 |
123,837,048 |
123,858,284 |
RGD:6480464 |
CTD |
| G |
Ttc38 |
tetratricopeptide repeat domain 38 |
|
increases expression |
ISO |
7 |
123,837,048 |
123,858,284 |
RGD:6480464 |
CTD |
| G |
Ttc39a |
tetratricopeptide repeat domain 39A |
|
multiple interactions |
ISO |
5 |
130,761,328 |
130,800,627 |
RGD:6480464 |
CTD |
| G |
Ttc39a |
tetratricopeptide repeat domain 39A |
|
increases expression |
ISO |
5 |
130,761,328 |
130,800,627 |
RGD:6480464 |
CTD |
| G |
Ttll9 |
tubulin tyrosine ligase-like family, member 9 |
|
affects methylation |
ISO |
3 |
143,304,937 |
143,351,359 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
increases expression |
EXP |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
| G |
Tuba1a |
tubulin, alpha 1A |
|
affects expression |
EXP |
7 |
137,729,405 |
137,733,071 |
RGD:6480464 |
CTD |
| G |
Tuba1b |
tubulin, alpha 1B |
|
increases expression |
EXP |
7 |
137,706,858 |
137,709,839 |
RGD:6480464 |
CTD |
| G |
Tuba1c |
tubulin, alpha 1C |
|
increases expression |
EXP |
7 |
137,809,847 |
137,817,451 |
RGD:6480464 |
CTD |
| G |
Tuba4a |
tubulin, alpha 4A |
|
increases expression |
EXP |
9 |
74,496,508 |
74,500,192 |
RGD:6480464 |
CTD |
| G |
Tuba8 |
tubulin, alpha 8 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tuba8 |
tubulin, alpha 8 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tubb2a |
tubulin, beta 2A class IIa |
|
multiple interactions |
ISO |
17 |
37,139,177 |
37,143,049 |
RGD:6480464 |
CTD |
| G |
Tubb2a |
tubulin, beta 2A class IIa |
|
decreases expression |
ISO |
17 |
37,139,177 |
37,143,049 |
RGD:6480464 |
CTD |
| G |
Tubb2a |
tubulin, beta 2A class IIa |
|
increases expression |
ISO |
17 |
37,139,177 |
37,143,049 |
RGD:6480464 |
CTD |
| G |
Tubb4b |
tubulin, beta 4B class IVb |
|
increases expression |
EXP |
3 |
3,387,050 |
3,389,500 |
RGD:6480464 |
CTD |
| G |
Tubb6 |
tubulin, beta 6 class V |
|
multiple interactions |
ISO |
18 |
63,919,776 |
63,929,415 |
RGD:6480464 |
CTD |
| G |
Tubb6 |
tubulin, beta 6 class V |
|
increases expression |
ISO |
18 |
63,919,776 |
63,929,415 |
RGD:6480464 |
CTD |
| G |
Tuft1 |
tuftelin 1 |
|
increases expression |
ISO |
2 |
189,595,242 |
189,621,686 |
RGD:6480464 |
CTD |
| G |
Tusc3 |
tumor suppressor candidate 3 |
|
affects expression |
ISO |
16 |
56,760,904 |
56,929,685 |
RGD:6480464 |
CTD |
| G |
Tusc3 |
tumor suppressor candidate 3 |
|
increases expression |
ISO |
16 |
56,760,904 |
56,929,685 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
multiple interactions |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
decreases expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases expression |
EXP |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
multiple interactions |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
EXP |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Txnrd2 |
thioredoxin reductase 2 |
|
increases expression |
ISO |
11 |
84,513,361 |
84,561,673 |
RGD:6480464 |
CTD |
| G |
Txnrd2 |
thioredoxin reductase 2 |
|
multiple interactions |
ISO |
11 |
84,513,361 |
84,561,673 |
RGD:6480464 |
CTD |
| G |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
|
multiple interactions |
ISO |
8 |
113,244,829 |
113,253,636 |
RGD:6480464 |
CTD |
| G |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
|
increases expression |
ISO |
8 |
113,244,829 |
113,253,636 |
RGD:6480464 |
CTD |
| G |
Ubd |
ubiquitin D |
|
multiple interactions |
ISO |
20 |
1,475,944 |
1,477,895 |
RGD:6480464 |
CTD |
| G |
Ubd |
ubiquitin D |
|
increases expression |
ISO |
20 |
1,475,944 |
1,477,895 |
RGD:6480464 |
CTD |
| G |
Ube2b |
ubiquitin-conjugating enzyme E2B |
|
increases expression |
EXP |
10 |
37,509,322 |
37,523,900 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
increases expression |
ISO |
3 |
155,800,357 |
155,802,757 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
multiple interactions |
ISO |
3 |
155,800,357 |
155,802,757 |
RGD:6480464 |
CTD |
| G |
Ube2d1 |
ubiquitin-conjugating enzyme E2D 1 |
|
increases expression |
ISO |
20 |
18,040,687 |
18,086,179 |
RGD:6480464 |
CTD |
| G |
Ube2d3 |
ubiquitin-conjugating enzyme E2D 3 |
|
decreases expression |
ISO |
2 |
232,943,214 |
232,971,022 |
RGD:6480464 |
CTD |
| G |
Ube2d3 |
ubiquitin-conjugating enzyme E2D 3 |
|
increases expression |
ISO |
2 |
232,943,214 |
232,971,022 |
RGD:6480464 |
CTD |
| G |
Ube2e2 |
ubiquitin-conjugating enzyme E2E 2 |
|
multiple interactions |
ISO |
15 |
8,554,863 |
8,828,088 |
RGD:6480464 |
CTD |
| G |
Ube2e2 |
ubiquitin-conjugating enzyme E2E 2 |
|
increases expression |
ISO |
15 |
8,554,863 |
8,828,088 |
RGD:6480464 |
CTD |
| G |
Ube2h |
ubiquitin-conjugating enzyme E2H |
|
affects expression |
ISO |
4 |
57,121,159 |
57,216,956 |
RGD:6480464 |
CTD |
| G |
Ube2t |
ubiquitin-conjugating enzyme E2T (putative) |
|
multiple interactions |
ISO |
13 |
47,924,340 |
47,934,842 |
RGD:6480464 |
CTD |
| G |
Ube2t |
ubiquitin-conjugating enzyme E2T (putative) |
|
increases expression |
ISO |
13 |
47,924,340 |
47,934,842 |
RGD:6480464 |
CTD |
| G |
Ubl3 |
ubiquitin-like 3 |
|
increases expression |
ISO |
12 |
7,019,485 |
7,063,818 |
RGD:6480464 |
CTD |
| G |
Ubqln1 |
ubiquilin 1 |
|
increases expression |
EXP |
17 |
12,370,389 |
12,418,868 |
RGD:6480464 |
CTD |
| G |
Ubxn7 |
UBX domain protein 7 |
|
increases expression |
ISO |
11 |
70,244,797 |
70,278,154 |
RGD:6480464 |
CTD |
| G |
Ugdh |
UDP-glucose 6-dehydrogenase |
|
increases expression |
EXP |
14 |
45,542,781 |
45,570,961 |
RGD:6480464 |
CTD |
| G |
Ugp2 |
UDP-glucose pyrophosphorylase 2 |
|
multiple interactions |
EXP |
14 |
102,072,724 |
102,113,561 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
EXP |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
EXP |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
|
increases expression |
EXP |
9 |
87,081,132 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
|
multiple interactions |
EXP |
9 |
87,081,132 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
|
increases expression |
EXP |
9 |
87,081,132 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a5 |
UDP glucuronosyltransferase 1 family, polypeptide A5 |
|
increases expression |
EXP |
9 |
87,052,169 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
increases expression |
EXP |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
increases expression |
EXP |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a8 |
UDP glycosyltransferase 1 family, polypeptide A8 |
|
increases expression |
EXP |
9 |
87,017,029 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a8 |
UDP glycosyltransferase 1 family, polypeptide A8 |
|
multiple interactions |
EXP |
9 |
87,017,029 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
increases expression |
EXP |
9 |
86,986,915 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
multiple interactions |
EXP |
9 |
86,986,915 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt2a3 |
UDP glucuronosyltransferase 2 family, polypeptide A3 |
|
affects expression |
ISO |
14 |
22,099,350 |
22,116,820 |
RGD:6480464 |
CTD |
| G |
Ugt2b |
UDP glycosyltransferase 2 family, polypeptide B |
|
increases expression |
EXP |
14 |
22,154,370 |
22,178,222 |
RGD:6480464 |
CTD |
| G |
Ugt2b10 |
UDP glucuronosyltransferase 2 family, polypeptide B10 |
|
multiple interactions |
ISO |
14 |
22,725,811 |
22,745,391 |
RGD:6480464 |
CTD |
| G |
Ugt2b10 |
UDP glucuronosyltransferase 2 family, polypeptide B10 |
|
increases expression |
ISO |
14 |
22,725,811 |
22,745,391 |
RGD:6480464 |
CTD |
| G |
Ugt2b15 |
UDP glucuronosyltransferase 2 family, polypeptide B15 |
|
increases activity |
EXP |
14 |
22,346,334 |
22,366,860 |
RGD:6480464 |
CTD |
| G |
Ugt2b15 |
UDP glucuronosyltransferase 2 family, polypeptide B15 |
|
increases expression |
EXP |
14 |
22,346,334 |
22,366,860 |
RGD:6480464 |
CTD |
| G |
Ugt2b15 |
UDP glucuronosyltransferase 2 family, polypeptide B15 |
|
multiple interactions |
EXP |
14 |
22,346,334 |
22,366,860 |
RGD:6480464 |
CTD |
| G |
Ugt2b17 |
UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
increases expression |
EXP |
14 |
22,639,182 |
22,650,931 |
RGD:6480464 |
CTD |
| G |
Ugt2b17 |
UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
increases expression |
EXP |
14 |
22,639,182 |
22,650,931 |
RGD:6480464 |
CTD |
| G |
Ugt8 |
UDP glycosyltransferase 8 |
|
increases expression |
EXP |
2 |
222,977,966 |
223,048,277 |
RGD:6480464 |
CTD |
| G |
Uhrf1 |
ubiquitin-like with PHD and ring finger domains 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Uhrf1 |
ubiquitin-like with PHD and ring finger domains 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Unc119b |
unc-119 homolog B (C. elegans) |
|
multiple interactions |
ISO |
12 |
42,750,444 |
42,763,067 |
RGD:6480464 |
CTD |
| G |
Unc119b |
unc-119 homolog B (C. elegans) |
|
increases expression |
ISO |
12 |
42,750,444 |
42,763,067 |
RGD:6480464 |
CTD |
| G |
Unc13b |
unc-13 homolog B (C. elegans) |
|
affects expression |
ISO |
5 |
59,551,928 |
59,768,901 |
RGD:6480464 |
CTD |
| G |
Uncx |
UNC homeobox |
|
increases expression |
EXP |
12 |
15,576,541 |
15,581,062 |
RGD:6480464 |
CTD |
| G |
Ung |
uracil-DNA glycosylase |
|
decreases expression |
EXP |
12 |
43,520,629 |
43,528,873 |
RGD:6480464 |
CTD |
| G |
Upb1 |
ureidopropionase, beta |
|
increases expression |
EXP |
20 |
13,715,995 |
13,743,261 |
RGD:6480464 |
CTD |
| G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
|
affects methylation |
ISO |
7 |
10,816,422 |
10,821,051 |
RGD:6480464 |
CTD |
| G |
Uroc1 |
urocanate hydratase 1 |
|
multiple interactions |
ISO |
4 |
124,591,873 |
124,622,726 |
RGD:6480464 |
CTD |
| G |
Uroc1 |
urocanate hydratase 1 |
|
decreases expression |
ISO |
4 |
124,591,873 |
124,622,726 |
RGD:6480464 |
CTD |
| G |
Usp18 |
ubiquitin specific peptidase 18 |
|
multiple interactions |
ISO |
4 |
157,692,720 |
157,694,884 |
RGD:6480464 |
CTD |
| G |
Usp18 |
ubiquitin specific peptidase 18 |
|
increases expression |
ISO |
4 |
157,692,720 |
157,694,884 |
RGD:6480464 |
CTD |
| G |
Usp2 |
ubiquitin specific peptidase 2 |
|
multiple interactions |
ISO |
8 |
47,052,085 |
47,076,321 |
RGD:6480464 |
CTD |
| G |
Usp2 |
ubiquitin specific peptidase 2 |
|
increases expression |
ISO |
8 |
47,052,085 |
47,076,321 |
RGD:6480464 |
CTD |
| G |
Usp20 |
ubiquitin specific peptidase 20 |
|
multiple interactions |
ISO |
3 |
10,048,393 |
10,080,966 |
RGD:6480464 |
CTD |
| G |
Usp20 |
ubiquitin specific peptidase 20 |
|
increases expression |
ISO |
3 |
10,048,393 |
10,080,966 |
RGD:6480464 |
CTD |
| G |
Usp22 |
ubiquitin specific peptidase 22 |
|
increases expression |
ISO |
10 |
47,303,727 |
47,327,738 |
RGD:6480464 |
CTD |
| G |
Usp22 |
ubiquitin specific peptidase 22 |
|
multiple interactions |
ISO |
10 |
47,303,727 |
47,327,738 |
RGD:6480464 |
CTD |
| G |
Usp6nl |
USP6 N-terminal like |
|
decreases expression |
ISO |
17 |
83,131,513 |
83,256,483 |
RGD:6480464 |
CTD |
| G |
Utrn |
utrophin |
|
increases expression |
EXP |
1 |
7,099,840 |
7,614,980 |
RGD:6480464 |
CTD |
| G |
Vav2 |
vav 2 guanine nucleotide exchange factor |
|
increases expression |
EXP |
3 |
6,153,681 |
6,347,676 |
RGD:6480464 |
CTD |
| G |
Vcp |
valosin-containing protein |
|
increases expression |
EXP |
5 |
59,472,100 |
59,491,508 |
RGD:6480464 |
CTD |
| G |
Vdac2 |
voltage-dependent anion channel 2 |
|
increases expression |
EXP |
15 |
2,515,297 |
2,528,969 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
decreases expression |
EXP |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
multiple interactions |
EXP |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Vldlr |
very low density lipoprotein receptor |
|
multiple interactions |
ISO |
1 |
230,666,736 |
230,697,748 |
RGD:6480464 |
CTD |
| G |
Vldlr |
very low density lipoprotein receptor |
|
affects expression |
ISO |
1 |
230,666,736 |
230,697,748 |
RGD:6480464 |
CTD |
| G |
Vldlr |
very low density lipoprotein receptor |
|
increases expression |
ISO |
1 |
230,666,736 |
230,697,748 |
RGD:6480464 |
CTD |
| G |
Vmp1 |
vacuole membrane protein 1 |
|
increases expression |
EXP |
10 |
74,865,123 |
74,964,158 |
RGD:6480464 |
CTD |
| G |
Vnn1 |
vanin 1 |
|
increases expression |
ISO |
1 |
22,087,290 |
22,097,592 |
RGD:6480464 |
CTD |
| G |
Vnn1 |
vanin 1 |
|
multiple interactions |
ISO |
1 |
22,087,290 |
22,097,592 |
RGD:6480464 |
CTD |
| G |
Vnn3 |
vanin 3 |
|
affects expression |
ISO |
1 |
22,121,744 |
22,134,006 |
RGD:6480464 |
CTD |
| G |
Vopp1 |
vesicular, overexpressed in cancer, prosurvival protein 1 |
|
multiple interactions |
ISO |
4 |
87,116,146 |
87,186,828 |
RGD:6480464 |
CTD |
| G |
Wfdc2 |
WAP four-disulfide core domain 2 |
|
decreases expression |
ISO |
3 |
155,582,378 |
155,588,056 |
RGD:6480464 |
CTD |
| G |
Wif1 |
Wnt inhibitory factor 1 |
|
multiple interactions |
ISO |
7 |
60,330,517 |
60,400,697 |
RGD:6480464 |
CTD |
| G |
Wif1 |
Wnt inhibitory factor 1 |
|
increases expression |
ISO |
7 |
60,330,517 |
60,400,697 |
RGD:6480464 |
CTD |
| G |
Wisp1 |
WNT1 inducible signaling pathway protein 1 |
|
multiple interactions |
ISO |
7 |
104,263,089 |
104,291,621 |
RGD:6480464 |
CTD |
| G |
Wisp1 |
WNT1 inducible signaling pathway protein 1 |
|
increases expression |
ISO |
7 |
104,263,089 |
104,291,621 |
RGD:6480464 |
CTD |
| G |
Wisp2 |
WNT1 inducible signaling pathway protein 2 |
|
multiple interactions |
ISO |
3 |
154,748,977 |
154,760,324 |
RGD:6480464 |
CTD |
| G |
Wisp2 |
WNT1 inducible signaling pathway protein 2 |
|
increases expression |
ISO |
3 |
154,748,977 |
154,760,324 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
multiple interactions |
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
increases expression |
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
Wscd1 |
WSC domain containing 1 |
|
affects methylation |
ISO |
10 |
58,616,509 |
58,645,325 |
RGD:6480464 |
CTD |
| G |
Wwc1 |
WW and C2 domain containing 1 |
|
decreases expression |
ISO |
10 |
20,750,770 |
20,910,298 |
RGD:6480464 |
CTD |
| G |
Wwox |
WW domain-containing oxidoreductase |
|
multiple interactions |
ISO |
19 |
44,516,391 |
44,829,849 |
RGD:6480464 |
CTD |
| G |
Wwox |
WW domain-containing oxidoreductase |
|
decreases expression |
ISO |
19 |
44,516,391 |
44,829,849 |
RGD:6480464 |
CTD |
| G |
Wwtr1 |
WW domain containing transcription regulator 1 |
|
multiple interactions |
ISO |
2 |
146,713,977 |
146,831,603 |
RGD:6480464 |
CTD |
| G |
Wwtr1 |
WW domain containing transcription regulator 1 |
|
increases expression |
ISO |
2 |
146,713,977 |
146,831,603 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
multiple interactions |
ISO |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
increases expression |
ISO |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xrcc4 |
X-ray repair complementing defective repair in Chinese hamster cells 4 |
|
affects expression |
ISO |
2 |
19,904,490 |
20,158,358 |
RGD:6480464 |
CTD |
| G |
Xrcc6bp1 |
XRCC6 binding protein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Yif1a |
Yip1 interacting factor homolog A (S. cerevisiae) |
|
increases methylation |
ISO |
1 |
207,711,277 |
207,715,338 |
RGD:6480464 |
CTD |
| G |
Yod1 |
YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae) |
|
increases expression |
ISO |
13 |
43,653,274 |
43,654,991 |
RGD:6480464 |
CTD |
| G |
Yrdc |
yrdC domain containing (E.coli) |
|
multiple interactions |
ISO |
5 |
144,183,573 |
144,188,418 |
RGD:6480464 |
CTD |
| G |
Yrdc |
yrdC domain containing (E.coli) |
|
decreases expression |
ISO |
5 |
144,183,573 |
144,188,418 |
RGD:6480464 |
CTD |
| G |
Ywhah |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
|
increases expression |
ISO |
14 |
83,448,395 |
83,457,778 |
RGD:6480464 |
CTD |
| G |
Ywhaq |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide |
|
increases expression |
EXP |
6 |
41,945,769 |
41,976,123 |
RGD:6480464 |
CTD |
| G |
Zap70 |
zeta-chain (TCR) associated protein kinase 70 |
|
multiple interactions |
ISO |
9 |
35,693,089 |
35,715,071 |
RGD:6480464 |
CTD |
| G |
Zap70 |
zeta-chain (TCR) associated protein kinase 70 |
|
decreases expression |
ISO |
9 |
35,693,089 |
35,715,071 |
RGD:6480464 |
CTD |
| G |
Zbtb5 |
zinc finger and BTB domain containing 5 |
|
multiple interactions |
ISO |
5 |
61,546,503 |
61,565,890 |
RGD:6480464 |
CTD |
| G |
Zbtb5 |
zinc finger and BTB domain containing 5 |
|
decreases expression |
ISO |
5 |
61,546,503 |
61,565,890 |
RGD:6480464 |
CTD |
| G |
Zbtb8os |
zinc finger and BTB domain containing 8 opposite strand |
|
affects methylation |
ISO |
5 |
148,492,643 |
148,504,132 |
RGD:6480464 |
CTD |
| G |
Zc3h12c |
zinc finger CCCH type containing 12C |
|
increases expression |
ISO |
8 |
55,478,499 |
55,531,853 |
RGD:6480464 |
CTD |
| G |
Zdhhc14 |
zinc finger, DHHC-type containing 14 |
|
multiple interactions |
ISO |
1 |
40,474,618 |
40,701,834 |
RGD:6480464 |
CTD |
| G |
Zdhhc14 |
zinc finger, DHHC-type containing 14 |
|
decreases expression |
ISO |
1 |
40,474,618 |
40,701,834 |
RGD:6480464 |
CTD |
| G |
Zfand2a |
zinc finger, AN1-type domain 2A |
|
multiple interactions |
ISO |
12 |
15,661,609 |
15,672,672 |
RGD:6480464 |
CTD |
| G |
Zfand2a |
zinc finger, AN1-type domain 2A |
|
decreases expression |
ISO |
12 |
15,661,609 |
15,672,672 |
RGD:6480464 |
CTD |
| G |
Zfand2a |
zinc finger, AN1-type domain 2A |
|
increases expression |
ISO |
12 |
15,661,609 |
15,672,672 |
RGD:6480464 |
CTD |
| G |
Zfp259 |
zinc finger protein 259 |
|
decreases expression |
ISO |
8 |
49,257,107 |
49,266,681 |
RGD:6480464 |
CTD |
| G |
Zfp28 |
zinc finger protein 28 |
|
increases expression |
ISO |
1 |
60,059,616 |
60,107,613 |
RGD:6480464 |
CTD |
| G |
Zfp354a |
zinc finger protein 354A |
|
affects expression |
ISO |
10 |
36,654,406 |
36,665,659 |
RGD:6480464 |
CTD |
| G |
Zfp354a |
zinc finger protein 354A |
|
affects expression |
EXP |
10 |
36,654,406 |
36,665,659 |
RGD:6480464 |
CTD |
| G |
Zfp36 |
zinc finger protein 36 |
|
decreases expression |
ISO |
1 |
83,486,643 |
83,489,123 |
RGD:6480464 |
CTD |
| G |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
|
decreases expression |
ISO |
6 |
103,119,555 |
103,124,576 |
RGD:6480464 |
CTD |
| G |
Zfp385a |
zinc finger protein 385A |
|
decreases expression |
ISO |
7 |
142,222,824 |
142,250,176 |
RGD:6480464 |
CTD |
| G |
Zfp385b |
zinc finger protein 385B |
|
increases expression |
ISO |
3 |
60,099,019 |
60,372,248 |
RGD:6480464 |
CTD |
| G |
Zfp445 |
zinc finger protein 445 |
|
decreases expression |
ISO |
8 |
127,543,965 |
127,562,919 |
RGD:6480464 |
CTD |
| G |
Zfp467 |
zinc finger protein 467 |
|
increases expression |
ISO |
4 |
76,522,000 |
76,528,470 |
RGD:6480464 |
CTD |
| G |
Zfp503 |
zinc finger protein 503 |
|
increases expression |
ISO |
15 |
2,352,911 |
2,356,699 |
RGD:6480464 |
CTD |
| G |
Zfp503 |
zinc finger protein 503 |
|
multiple interactions |
ISO |
15 |
2,352,911 |
2,356,699 |
RGD:6480464 |
CTD |
| G |
Zfp536 |
zinc finger protein 536 |
|
affects expression |
ISO |
1 |
89,794,391 |
90,036,876 |
RGD:6480464 |
CTD |
| G |
Zfp704 |
zinc finger protein 704 |
|
multiple interactions |
ISO |
2 |
94,202,644 |
94,394,132 |
RGD:6480464 |
CTD |
| G |
Zfp704 |
zinc finger protein 704 |
|
increases expression |
ISO |
2 |
94,202,644 |
94,394,132 |
RGD:6480464 |
CTD |
| G |
Zfp799 |
zinc finger protein 799 |
|
increases expression |
ISO |
7 |
13,475,889 |
13,488,523 |
RGD:6480464 |
CTD |
| G |
Zfp810 |
zinc finger protein 810 |
|
increases expression |
ISO |
8 |
21,581,895 |
21,598,594 |
RGD:6480464 |
CTD |
| G |
Zfr |
zinc finger RNA binding protein |
|
increases expression |
ISO |
2 |
61,578,795 |
61,641,287 |
RGD:6480464 |
CTD |
| G |
Zmat1 |
zinc finger, matrin-type 1 |
|
increases expression |
ISO |
X |
122,455,355 |
122,484,808 |
RGD:6480464 |
CTD |
| G |
Zmat3 |
zinc finger, matrin type 3 |
|
increases expression |
EXP |
2 |
118,526,985 |
118,537,727 |
RGD:6480464 |
CTD |
| G |
Zmpste24 |
zinc metallopeptidase STE24 |
|
affects expression |
ISO |
5 |
141,644,119 |
141,677,211 |
RGD:6480464 |
CTD |
| G |
Zmynd8 |
zinc finger, MYND-type containing 8 |
|
decreases expression |
ISO |
3 |
156,860,459 |
156,957,748 |
RGD:6480464 |
CTD |
| G |
Znfx1 |
zinc finger, NFX1-type containing 1 |
|
increases expression |
EXP |
3 |
158,187,092 |
158,246,947 |
RGD:6480464 |
CTD |
| G |
Znrf3 |
zinc and ring finger 3 |
|
multiple interactions |
ISO |
14 |
85,927,245 |
85,982,249 |
RGD:6480464 |
CTD |
| G |
Znrf3 |
zinc and ring finger 3 |
|
increases expression |
ISO |
14 |
85,927,245 |
85,982,249 |
RGD:6480464 |
CTD |
| G |
Zscan22 |
zinc finger and SCAN domain containing 22 |
|
affects methylation |
ISO |
1 |
72,812,464 |
72,816,283 |
RGD:6480464 |
CTD |
| G |
Zwilch |
zwilch kinetochore protein |
|
multiple interactions |
ISO |
8 |
68,334,038 |
68,366,291 |
RGD:6480464 |
CTD |
| G |
Zwilch |
zwilch kinetochore protein |
|
increases expression |
ISO |
8 |
68,334,038 |
68,366,291 |
RGD:6480464 |
CTD |
Term paths to the root
|